Profil

Moutschen Michel

Vice-Recteur à la Recherche

Département des sciences cliniques > Immunopath. - Maladies infect. et médec. interne gén.

GIGA I3 - Immunology & Infectious Diseases

See author's contact details
ORCID
0000-0002-6405-1785
Main Referenced Co-authors
Darcis, Gilles  (49)
Rahmouni, Souad  (43)
Léonard, Philippe  (39)
Vaira, Dolorès  (39)
Frippiat, Frédéric  (29)
Main Referenced Keywords
Humans (82); Male (32); Female (31); Adult (28); Middle Aged (25);
Main Referenced Unit & Research Centers
GIGA-I3 - Giga-Infection, Immunity and Inflammation - ULiège (13)
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège [BE] (7)
CEIB - Centre Interfacultaire des Biomatériaux - ULiège [BE] (2)
SPHERES - ULiège [BE] (2)
CHU de Liège (1)
Main Referenced Disciplines
Immunology & infectious disease (207)
General & internal medicine (18)
Laboratory medicine & medical technology (16)
Biochemistry, biophysics & molecular biology (15)
Endocrinology, metabolism & nutrition (14)

Publications (total 301)

The most downloaded
2928 downloads
Nkoghe, D., Moutschen, M., & Demonty, J. (2008). Lesions cerebrales demyelinisantes decouvertes chez un patient immunocompetent VIH-1+. Médecine et Maladies Infectieuses, 38 (9), 500-3. doi:10.1016/j.medmal.2008.06.010 https://hdl.handle.net/2268/73698

The most cited

663 citations (Scopus®)

Gulick, R. M., Lalezari, J., Goodrich, J., Clumeck, N., DeJesus, E., Horban, A., Nadler, J., Clotet, B., Karlsson, A., Wohlfeiler, M., Montana, J. B., McHale, M., Sullivan, J., Ridgway, C., Felstead, S., Dunne, M. W., van der Ryst, E., Mayer, H., & Moutschen, M. (Other coll.). (2008). Maraviroc for previously treated patients with R5 HIV-1 infection. New England Journal of Medicine, 359 (14), 1429-41. doi:10.1056/NEJMoa0803152 https://hdl.handle.net/2268/16313

Ebo, D. G., Van der Poorten, M. M., Van Gasse, A. L., Schrijvers, R., Hermans, C., Bartiaux, M., Haerynck, F., Willekens, J., Lapeere, H., Moutschen, M., Michel, O., & Sabato, V. (December 2023). Clinical practice of hereditary angioedema in Belgium: opportunities for optimized care. Acta Clinica Belgica, 78 (6), 431 - 437. doi:10.1080/17843286.2023.2213491
Peer Reviewed verified by ORBi

Scheen, A., Louis, R., Lancellotti, P., Jouret, F., Delwaide, J., & Moutschen, M. (November 2023). Vaccination antipneumococcique dans les groupes à risque avec comorbidités : recommandations du Conseil Supérieur de la Santé et critères de remboursement. Revue Médicale de Liège, 78 (11), 665 - 673.
Editorial Reviewed verified by ORBi

Misset, B., Piagnerelli, M., Hoste, E., Dardenne, N., Grimaldi, D., Michaux, I., De Waele, E., Dumoulin, A., Jorens, P. G., van der Hauwaert, E., Vallot, F., Lamote, S., Swinnen, W., De Schryver, N., Fraipont, V., de Mey, N., Dauby, N., Layios, N., Mesland, J.-B., ... Laterre, P.-F. (26 October 2023). Convalescent Plasma for Covid-19–Induced ARDS in Mechanically Ventilated Patients. New England Journal of Medicine, 389 (17), 1590-1600. doi:10.1056/nejmoa2209502
Peer Reviewed verified by ORBi

Misset, B., Nguyet, A. D., BERTRAND, A., Piagnerelli, M., Hoste, E., de Waele, E., Dumoulin, A., Jorens, P., van der Hauwaert, E., Vallot, F., Swinnen, W., De Schryver, N., de Mey, N., Layios, N., Mesland, J., Robinet, S., Cavalier, E., Donneau, A.-F., Moutschen, M., & Laterre, P. F. (24 October 2023). Immunological sub-phenotypes and response to Convalescent-Plasma (CP) in COVID-19 induced ARDS (C-ARDS): a hierarchical cluster analysis [Poster presentation]. ESICM LIVES 2023, Milan, Italy.
Peer reviewed

Martinez, E., Crevecoeur, S., THIRION, C., GRANDJEAN, J., Fall, P. A., Hayette, M.-P., Moutschen, M., Taminiau, B., Louis, E., & Daube, G. (10 October 2023). Gut Microbiota Associated with Clostridioides difficile Carriage in Three Clinical Groups (Inflammatory Bowel Disease, C. difficile Infection and Healthcare Workers) in Hospital Field. Microorganisms, 11 (10), 2527. doi:10.3390/microorganisms11102527
Peer Reviewed verified by ORBi

Fombellida-Lopez, C., Pasternak, A. O., Cicilionyté, A., Maes, N., Vanwinge, C., Ormenese, S., Ladang, A., Cavalier, E., Winchester, L., Fletcher, C., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., & Darcis, G. (11 September 2023). Doubling dolutegravir dosage reduces HIV persistence markers in ART-treated adults [Poster presentation]. HIV Cure Symposium 2023, Gand, Belgium.

COVID-19 Host Genetics Initiative, Rahmouni, S., Georges, M., Moutschen, M., Darcis, G., & Beguin, Y. (September 2023). A second update on mapping the human genetic architecture of COVID-19. Nature, 621 (7977), 7 - E26. doi:10.1038/s41586-023-06355-3
Peer Reviewed verified by ORBi

Kayembe Ntumba, H. C., Bompangue, D., Linard, C., Mandja, B.-A., Batumbo, D., Matunga, M., Muwonga, J., Moutschen, M., Situakibanza, H., & Ozer, P. (28 August 2023). Drivers of the dynamics of the spread of cholera in the Democratic Republic of the Congo, 2000-2018: An eco-epidemiological study. PLoS Neglected Tropical Diseases, 17 (8), 0011597. doi:10.1371/journal.pntd.0011597
Peer Reviewed verified by ORBi

Misset, B., Piagnerelli, M., Hoste, E., Dardenne, N., Grimaldi, D., Michaux, I., De Waele, E., Dumoulin, A., Jorens, P., Layios, N., Moutschen, M., Desmecht, D., Gothot, A., & Laterre, P. F. (14 June 2023). Proceedings of Reanimation 2023, the French Intensive Care Society International CongressCO‐59 Secondary outcomes of the CONFIDENT randomized trial of convalescent plasma therapy with high titers of neutralizing antibodies (NAb) in COVID-ARDS patients [Poster presentation]. SRLF annual meeting 2023, Paris, France. doi:10.1186/s13613-023-01131-y
Peer reviewed

Burniat, A., Noël, A., Colige, A., Vanderplasschen, A., de Kerchove d'Exaerde, A., Kupper Cardozo, A., Van Keymeulen, A., Moens, A., Bondue, A., Herpain, A., Marchant, A., Loumaye, A., Beck, B., Van den Heyden, B., Corvilain, B., Lakaye, B., Rogister, B., Malgrange, B., Michiels, C., ... Brunko, E. (2023). Cent scientifiques répliquent à SEA (Suppression des Expériences sur l’Animal vivant) et dénoncent sa désinformation. La Libre Belgique.

Fombellida-Lopez, C., Pasternak, A. O., Cicilionyté, A., Maes, N., Vanwinge, C., Ormenese, S., Ladang, A., Cavalier, E., Winchester, L., Fletcher, C., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., & Darcis, G. (21 February 2023). Doubling dolutegravir dosage reduces HIV persistence markers in ART-treated adults [Poster presentation]. Conference on Retroviruses and Opportunistic Infection (CROI 2023), Seattle, United States.

Van der Poorten, M. M., Schrijvers, R., Hermans, C., Bartiaux, M., Haerynck, F., Lapeere, H., Moutschen, M., Michel, O., Sabato, V., Ebo, D. G., & Van Gasse, A. L. (2023). Hereditary angioedema (HAE) in Belgium: results from a national survey. Frontiers in Allergy, 4, 1143897. doi:10.3389/falgy.2023.1143897
Peer Reviewed verified by ORBi

Mayasi Ngongo, N., Kamangu Ntambwe, E., Situakibanza Nani-Tuma, H., Mbula Mambimbi, M., Mandina Ndona, M., Longokolo Mashi, M., Bepouka Izizag, B., Lukiana, T., Odio Ossam, J., Mangala Sonzi, D., Maes, N., Moutschen, M., El Moussaoui, M., & Darcis, G. (2023). Human Immunodeficiency Virus Viral Load Monitoring and Rate of Virologic Suppression Among Patients Receiving Antiretroviral Therapy in Democratic Republic of the Congo, 2013-2020. Open Forum Infectious Diseases, 10 (6), 2-7. doi:10.1093/ofid/ofad242
Peer Reviewed verified by ORBi

Schober, R., Brandus, B., Laeremans, T., Iserentant, G., Rolin, C., Dessilly, G., Zimmer, J., Moutschen, M., Aerts, J. L., Dervillez, X., & Seguin-Devaux, C. (2023). Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure. Journal of Translational Medicine, 21 (1), 791. doi:10.1186/s12967-023-04669-4
Peer Reviewed verified by ORBi

Amand, M., Adams, P., Schober, R., Iserentant, G., Servais, J.-Y., Moutschen, M., & Seguin-Devaux, C. (2023). The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4+ T cell depletion, viral load, and total HIV-1 DNA in HIV-1 infected humanized mice. eLife, 12 (February), 83207. doi:10.7554/eLife.83207
Peer Reviewed verified by ORBi

Bernard, D., Taminiau, B., Medlej, M., Moutschen, M., Misset, B., Daube, G., & Rousseau, A.-F. (2023). Oropharyngeal bacterial microbiota analysis at hospital admission: a comparison of COVID-19 and cerebral vascular disease patients. Annals of Intensive Care, 13 (Suppl 1), 048.
Peer Reviewed verified by ORBi

El Moussaoui, M., Desmecht, S., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., Toussaint, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., GREGOIRE, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (2023). Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIV. Viruses, 15, 1435. doi:10.3390/v15071435
Peer Reviewed verified by ORBi

Fombellida-Lopez, C., Pasternak, A. O., Cicilionyté, A., Maes, N., Vanwinge, C., Ormenese, S., Ladang, A., Cavalier, E., Winchester, L., Fletcher, C., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., & Darcis, G. (23 November 2022). Doubling dolutegravir dosage reduces HIV persistence markers in ART-treated adults [Poster presentation]. Belgium Research on AIDS and HIV Consortium (BREACH 2022), Bruxelles, Belgium.

Zono, B., Sacheli, R., Nani-Tuma, H. S., Mavanga, A., Mwambi, J. A., Etondo, M., Kasumba, D. M., Moutschen, M., Lelo, G. M., & Hayette, M.-P. (20 September 2022). P461 Cryptococcosis screening and isolates characterization in asymptomatic people living with HIV in Kinshasa, DRC [Poster presentation]. ISHAM 2022 Congress. doi:10.1093/mmy/myac072.p461
Peer reviewed

Paridans, M., Monseur, J., Donneau, A.-F., Gillain, N., Husson, E., Leclercq, D., Meuris, C., Darcis, G., Moutschen, M., Saegerman, C., Gillet, L., Bureau, F., Guillaume, M., & Pétré, B. (2022). The Dynamic Relationship between the Intention and Final Decision for the COVID-19 Booster: A Study among Students and Staff at the University of Liège, Belgium. Vaccines. doi:10.3390/vaccines10091485
Peer Reviewed verified by ORBi

El Moussaoui, M., Desmecht, S., Tashkeev, A., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., TOUSSAINT, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., Grégoire, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (05 September 2022). Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIV. Journal of Infection, 85, 751-755. doi:10.1016/j.jinf.2022.09.006
Peer Reviewed verified by ORBi

El Moussaoui, M., Maes, N., Fombellida, K., VAIRA, D., Moutschen, M., & Darcis, G. (02 September 2022). Impact de la pandémie de Covid-19 sur les soins de santé des personnes vivant avec le VIH à Liège, Belgique [Paper presentation]. Congrès annuel de l'Association Latine pour l'Analyse des Systèmes de Santé (CALASS), Barcelone, Spain.
Peer reviewed

BONIVER, M., Wotquenne, P., Moutschen, M., & Rousseau, A.-F. (September 2022). La phagothérapie, un complément prometteur dans notre arsenal thérapeutique face aux bactéries multirésistantes. Revue Médicale de Liège, 77 (9), 510 - 515.
Peer reviewed

De Leeuw, E.* , Van Damme, K. F. A.* , Declercq, J.* , Bosteels, C.* , Maes, B., Tavernier, S. J., Detalle, L., Smart, T., Glatt, S., Debeuf, N., Deckers, J., Lameire, S., Vandecasteele, S. J., De Neve, N., Demedts, I. K., Govaerts, E., Knoop, C., Vanhove, K., Moutschen, M., ... Lambrecht, B. N. (09 August 2022). Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial. Respiratory Research, 23 (202), 1-11. doi:10.1186/s12931-022-02126-2
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Pathak, G. A., Karjalainen, J., Stevens, C., Neale, B. M., Daly, M., Ganna, A., Andrews, S. J., Kanai, M., Cordioli, M., Polimanti, R., Harerimana, N., Pirinen, M., Liao, R. G., Chwialkowska, K., Trankiem, A., Balaconis, M. K., Nguyen, H., Solomonson, M., Veerapen, K., ... Baillie, J. K. (03 August 2022). A first update on mapping the human genetic architecture of COVID-19. Nature, 608, 1-E10. doi:10.1038/s41586-022-04826-7
Peer Reviewed verified by ORBi

Maes, N., Rolland, J., Boutin, R., Codet, M., Lecleve, A., Schils, R., THYS, M., Albert, A., Moutschen, M., & Kolh, P. (07 July 2022). Développement et évaluation d’un outil d’aide à la décision clinique pour le suivi des patients hospitalisés pour COVID-19 au CHU de Liège [Paper presentation]. Conférence Francophone en Gestion et Ingénierie des Systèmes Hospitaliers (GISEH), Saint Etienne, France.
Peer reviewed

Absil, G., SOUGNE, L., LAHRICHI, D., Collins, P., Meuris, C., Moutschen, M., Nikkels, A., & Orban, C. (July 2022). Variole du singe. Revue Médicale de Liège, 77 (7), 452-455.
Editorial Reviewed verified by ORBi

El Moussaoui, M., Maes, N., Hong, S. L., Lambert, N., Gofflot, S., DELLOT, P., Belhadj, Y., Huynen, P., Hayette, M.-P., Meex, C., Bontems, S., Defêche, J., Godderis, L., Molenberghs, G., Meuris, C., Artesi, M., Durkin, K., Rahmouni, S., GREGOIRE, C., ... DARCIS, G. (14 June 2022). Evaluation of Screening Program and Phylogenetic Analysis of SARS-CoV-2 Infections among Hospital Healthcare Workers in Liège, Belgium. Viruses, 14 (6), 1302. doi:10.3390/v14061302
Peer Reviewed verified by ORBi

GREGOIRE, C.* , HUYNEN, P.* , Gofflot, S., Seidel, L., Maes, N., VRANKEN, L., DELCOUR, S., MOUTSCHEN, M., HAYETTE, M.-P., KOLH, P., MELIN, P., & BEGUIN, Y. (13 June 2022). Predictive factors for the presence and long-term persistence of SARS-CoV-2 antibodies in healthcare and university workers. Scientific Reports, 12, 9790. doi:10.1038/s41598-022-13450-4
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Misset, B., Piagnerelli Michaël, Hoste Eric, Dardenne, N., Grimaldi D., Michaux, I., Dumoulin, A., Jorens, P., van der Hauwaert, E., de Waele, E., Vallot, F., Lamote, S., Swinnen, W., Fraipont, V., de Mey, N., de Schryver, N., de Wit, S., Layios, N., Mesland, J., ... Laterre, P. F. (June 2022). Convalescent plasma therapy with high titers of neutralizing antibodies to reduce mortality in patients with COVID-19 associated ARDS: the Belgian randomized CONFIDENT trial [Poster presentation]. SIZ Annual Meeting, Bruxelles, Belgium.
Peer reviewed

Zono, B.* , SACHELI, R.* , Situakibanza Nani-Tuma, H.* , Kabututu Zakayi, P.* , Ka, A.* , Mbula Mambimbi, M.* , Muendele, G.* , BOREUX, R.* , Landu, N.* , Nzanzu Mudogo, C.* , M'Buze, P.-R.* , MOUTSCHEN, M.* , Meyer, W.* , Mvumbi Lelo, G.* , & HAYETTE, M.-P.*. (19 May 2022). Clinical epidemiology and high genetic diversity amongst Cryptococcus spp. isolates infecting people living with HIV in Kinshasa, Democratic Republic of Congo. PLoS ONE, 17 (5), 0267842. doi:10.1371/journal.pone.0267842
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

HUYNEN, P.* , GREGOIRE, C.* , GOFFLOT, S., SEIDEL, L., MAES, N., VRANKEN, L., DELCOUR, S., MOUTSCHEN, M., HAYETTE, M.-P., KOLH, P., MELIN, P., & BEGUIN, Y. (25 March 2022). Long-term longitudinal evaluation of the prevalence of SARS-CoV-2 antibodies in healthcare and university workers. Scientific Reports, 12 (1), 5156. doi:10.1038/s41598-022-09215-8
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Mayasi, N., Situakibanza, H., Mbula, M., Longokolo, M., Maes, N., Bepouka, B., Ossam, J. O., MOUTSCHEN, M., & DARCIS, G. (11 March 2022). Retention in care and predictors of attrition among HIV-infected patients who started antiretroviral therapy in Kinshasa, DRC, before and after the implementation of the ‘treat-all’ strategy. PLOS Global Public Health, 2 (3), 0000259. doi:10.1371/journal.pgph.0000259
Peer reviewed

Kayembe Ntumba, H. C., Linard, C., Bompangue, D., Muwonga, J., MOUTSCHEN, M., Situakibanza, H., & Ozer, P. (07 February 2022). Modalities and preferred routes of geographic spread of cholera from endemic areas in eastern Democratic Republic of the Congo. PLoS ONE, 17 (2), 0263160. doi:10.1371/journal.pone.0263160
Peer Reviewed verified by ORBi

Devos, T., Van Thillo, Q., Compernolle, V., Najdovski, T., Romano, M., Dauby, N., Jadot, L., Leys, M., Maillart, E., Loof, S., Seyler, L., Moonen, M., MOUTSCHEN, M., Van Regenmortel, N., Ariën, K. K., Barbezange, C., Betrains, A., Garigliany, M.-M., Engelen, M. M., ... DAWn-plasma, I. (February 2022). Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma. European Respiratory Journal, 59 (2). doi:10.1183/13993003.01724-2021
Peer Reviewed verified by ORBi

Scheen, A., Louis, R., & Moutschen, M. (2022). Apexxnar®, vaccin anti-pneumococcique conjugué avec 20 sérotypes. Revue Médicale de Liège, 77 (11), 678 - 683.
Editorial Reviewed verified by ORBi

Egg, D., Rump, I. C., Mitsuiki, N., Rojas-Restrepo, J., Maccari, M.-E., Schwab, C., Gabrysch, A., Warnatz, K., Goldacker, S., Patiño, V., Wolff, D., Okada, S., Hayakawa, S., Shikama, Y., Kanda, K., Imai, K., Sotomatsu, M., Kuwashima, M., Kamiya, T., ... Grimbacher, B. (2022). Therapeutic options for CTLA-4 insufficiency. Journal of Allergy and Clinical Immunology, 149 (2), 736 - 746. doi:10.1016/j.jaci.2021.04.039
Peer Reviewed verified by ORBi

Van Beckhoven, D., Serrien, B., Montourcy, M., Verhofstede, C., Van den Bossche, D., Libois, A., De Geyter, D., Martin, T., Van den Eynde, S., Vuylsteke, B., Darcis, G., van Halem, K., Florence, E., Deblonde, J., Ausselet, N. (Other coll.), Delforge, M.-L. (Other coll.), Demeester, R. (Other coll.), De Munter, P. (Other coll.), Goffard, J.-C. (Other coll.), ... Yombi, J.-C. (Other coll.). (2022). Impact of COVID-19 on the Belgian HIV epidemic: slowdown of HIV transmission and testing and adaptation of care. BMC Infectious Diseases, 22 (1), 901. doi:10.1186/s12879-022-07879-1
Peer Reviewed verified by ORBi

Lengele, L., Locquet, M., Moutschen, M., Beaudart, C., Kaux, J.-F., Gillain, S., Shadouh, C., Reginster, J.-Y., & Bruyère, O. (2022). Relationships between malnutrition, sarcopenia, and frailty and the incidence of Covid-19 in older adults: data from the sarcophage cohort. Osteoporosis International, 32 (Suppl 1), 50.
Peer Reviewed verified by ORBi

Cambier, M., Henket, M., Frix, A.-N., Gofflot, S., THYS, M., Tomasetti, S., Peired, A., Struman, I., Rousseau, A.-F., Misset, B., Darcis, G., Moutschen, M., Louis, R., Njock, M.-S., Cavalier, E., & Guiot, J. (2022). Increased KL-6 levels in moderate to severe COVID-19 infection. PLoS ONE, 17 (11), 0273107. doi:10.1371/journal.pone.0273107
Peer Reviewed verified by ORBi

Donneau, A.-F.* , Guillaume, M.* , BOURS, V., Dandoy, M., DARCIS, G., Desmecht, D., Diep, A. N., Fievez, L., Garigliany, M.-M., Gillain, N., Husson, E., Michel, F., MOUTSCHEN, M., Paridans, M., Pétré, B., Sabatel, C., Saegerman, C., Tytgat, A., Gillet, L.* , & Bureau, F.*. (2022). University population-based prospective cohort study of SARS-CoV- 2 infection and immunity (SARSSURV-ULiège): a study protocol. BMJ Open. doi:10.1136/bmjopen-2021-055721
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Desmecht, S.* , Tashkeev, A.* , El Moussaoui, M., MARECHAL, N., Perée, H., Tokunaga, Y., Fombellida-Lopez, C., Polese, B., Legrand, C., Wéry, M., Mni, M., Fouillien, N., TOUSSAINT, F., Gillet, L., Bureau, F., LUTTERI, L., HAYETTE, M.-P., MOUTSCHEN, M., MEURIS, C., ... DARCIS, G.*. (2022). Kinetics and persistence of the cellular and humoral immune responses to BNT162b2 mRNA vaccine in SARS-CoV-2-naive and -experienced subjects: impact of booster dose and breakthrough infections. Frontiers in Immunology, 13, 863554. doi:10.3389/fimmu.2022.863554
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Moutschen, M. (2022). Maladies auto-inflammatoires monogéniques : une introduction sur un mode translationnel aux inflammasomopathies. Revue Médicale de Liège, 77 (5-6), 392 - 398.
Editorial Reviewed verified by ORBi

Lengele, L., Locquet, M., Moutschen, M., Beaudart, C., KAUX, J.-F., Gillain, S., Reginster, J.-Y., & Bruyère, O. (January 2022). Frailty but not sarcopenia nor malnutrition increases the risk of developing COVID-19 in older community-dwelling adults. Aging Clinical and Experimental Research, 34 (1), 223-234. doi:10.1007/s40520-021-01991-z
Peer Reviewed verified by ORBi

Kayembe Ntumba, H. C.* , Linard, C.* , Bompangue, D.* , Muwonga, J.* , MOUTSCHEN, M.* , Situakibanza, H.* , & Ozer, P.*. (19 December 2021). The spread of cholera in western Democratic Republic of the Congo is not unidirectional from East–West: a spatiotemporal analysis, 1973–2018. BMC Infectious Diseases, 21 (1), 1261.
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Kayembe Ntumba, H. C., Linard, C., Bompangue, D., Muwonga, J., Moutschen, M., Situakibanza, H., & Ozer, P. (19 December 2021). The spread of cholera in western Democratic Republic of the Congo is not unidirectional from East-West: a spatiotemporal analysis, 1973-2018. BMC Infectious Diseases, 21 (1), 1261. doi:10.1186/s12879-021-06986-9
Peer Reviewed verified by ORBi

Zono, B., MOUTSCHEN, M., Situakibanza, H., SACHELI, R., Kabututu, P., Mvumbi, G., & HAYETTE, M.-P. (10 December 2021). Comparaison des caractéristiques cliniques et biologiques des PVVIH présentant une méningite à Cryptococcus neoformans versus C. curvatus/C. laurentii [Paper presentation]. Journées scientifiques PNLS/RDC, Kinshasa, Congo - Kinshasa.

Zono, B., SACHELI, R., Situakibanza, H., Kabututu, P., MOUTSCHEN, M., Mvumbi, G., & HAYETTE, M.-P. (10 December 2021). Épidémiologie clinique et caractérisation moléculaire d’isolats de Cryptococcus spp. infectant les PVVIH à Kinshasa, RDC [Paper presentation]. Journées scientifiques PNLS, Kinshasa, Congo - Kinshasa.

El Moussaoui, M., Lambert, N., MAES, N., Fombellida, K., VAIRA, D., MOUTSCHEN, M., & DARCIS, G. (30 November 2021). Impact of the COVID-19 pandemic situation on HIV care in Liège, Belgium [Poster presentation]. BREACH Symposium 2021, Bruxelles, Belgium.

Muraille, E., De Kerchove d'Exaerde, A., Drion, P., Vanderplasschen, A., Lambermont, B., Rogister, B., Muylkens, B., Vassart, G., Balthazart, J., Pillot, J., Pastushenko, L., Moutschen, M., LEONARD, P., Naccache, P., Costagliola, S., & Guerin, S. (2021). "Opter pour l'obligation vaccinale est un choix de société". Le Vif. L'Express.

Zono, B., MOUTSCHEN, M., SITUAKIBANZA, H., SACHELI, R., MUENDELE, G., KABUTUTU, P., BIAKABUSWA, A., LANDU, N., MVUMBI, G., & Hayette, M.-P. (15 November 2021). Comparison of clinical and biological characteristics of HIV infected patients presenting Cryptococcus neorformans versus C. curvatus /C. laurentii meningitis. BMC Infectious Diseases, 21 (1), 1-10. doi:10.1186/s12879-021-06849-3
Peer Reviewed verified by ORBi

Zono, B., SACHELI, R., Situakibanza, H., Kabututu, P., Mbula, M., Muendele, G., BOREUX, R., Landu, N., Mudogo, C., M'buze, P.-R., Moutschen, M., Mvumbi, G., & Hayette, M.-P. (28 October 2021). Molecular Analysis of Cryptococcus spp. Reveals Species Diversity and Multilocus Sequence Typing Heterogeneity among People Living with HIV in Kinshasa. Journal of Fungi, 7 (916), 42-43. doi:10.3390/jof7110916
Peer Reviewed verified by ORBi

Nakanishi, T., Pigazzini, S., Degenhardt, F., Cordioli, M., Butler-Laporte, G., Maya-Miles, D., Nafría-Jiménez, B., Bouysran, Y., Niemi, M., Palom, A., Ellinghaus, D., Khan, A., Martínez-Bueno, M., Rolker, S., Amitano, S., Tato, L. R., Fava, F., Spinner, C. D., Prati, D., ... consortium, C.-H. (October 2021). Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. Journal of Clinical Investigation, Online ahead of print.. doi:10.1172/JCI152386
Peer Reviewed verified by ORBi

El Moussaoui, M., Lambert, N., MAES, N., Fombellida, K., VAIRA, D., MOUTSCHEN, M., & DARCIS, G. (2021). Impact of the COVID-19 pandemic situation on HIV care in Liège, Belgium. HIV Research & Clinical Practice. doi:10.1080/25787489.2021.1948773
Peer Reviewed verified by ORBi

Zono, B., MOUTSCHEN, M., Situakibanza, H., Kabututu, P., Mvumbi, G., & Hayette, M.-P. (12 June 2021). Comparison of clinical and biological characteristics of HIV infected patients presenting Cryptococcus neorformans versus C. curvatus /C. laurentii meningitis [Poster presentation]. MYCOLOGY 2021, London - Online, United Kingdom.

Lambert, N., Hansen, I., El Moussaoui, M., GIOT, J.-B., Vercheval, C., LOMMERS, E., SOMJA, J., MOUTSCHEN, M., & MAQUET, P. (2021). Lung and liver sarcoidosis‐like reaction induced by tocilizumab. British Journal of Clinical Pharmacology. doi:10.1111/bcp.14878
Peer Reviewed verified by ORBi

Detry, O., MEURISSE, N., Jouret, F., BLETARD, N., Delwaide, J., & Moutschen, M. (February 2021). Immunosuppression Withdrawal After Liver Transplantation for Common Variable Immunodeficiency. Liver Transplantation, 27 (3), 456-458. doi:10.1002/lt.25873
Peer Reviewed verified by ORBi

Plum, P.-E., Maes, N., Sauvage, A.-S., Frippiat, F., Meuris, C., Uurlings, F., Lecomte, M., Léonard, P., Paquot, N., Fombellida, K., Vaira, D., Moutschen, M., & Darcis, G. (2021). Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV. BMC Infectious Diseases, 21 (1), 910. doi:10.1186/s12879-021-06479-9
Peer Reviewed verified by ORBi

Nasreddine, R., Florence, E., Moutschen, M., Yombi, J.-C., Goffard, J.-C., Derdelinckx, I., Lacor, P., Vandekerckhove, L., Messiaen, P., Vandecasteele, S., Delforge, M., De Wit, S., & Belgian Research on AIDS and HIV Consortium (BREACH). (2021). Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort. Journal of Medical Virology, 93 (5), 2971 - 2978. doi:10.1002/jmv.26828
Peer Reviewed verified by ORBi

Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x
Peer Reviewed verified by ORBi

Jacques, S., Arjomand, A., Perée, H., COLLINS, P., Mayer, A., Lavergne, A., Wéry, M., Mni, M., Hego, A., Thuillier, V., Becker, G., Bahri, M. A., Plenevaux, A., Di Valentin, E., Oury, C., MOUTSCHEN, M., Delvenne, P., Paquot, N., & Rahmouni, S. (2021). Dual‑specificity phosphatase 3 deletion promotes obesity, non‑alcoholic steatohepatitis and hepatocellular carcinoma. Scientific Reports, 11, 5817. doi:10.1038/s41598-021-85089-6
Peer Reviewed verified by ORBi

Adams, P., Fievez, V., Schober, R., Amand, M., Iserentant, G., Rutsaert, S., Dessilly, G., Vanham, G., Hedin, F., Cosma, A., Moutschen, M., Vandekerckhove, L., & Seguin-Devaux, C. (2021). CD32+CD4+ memory T cells are enriched for total HIV-1 DNA in tissues from humanized mice. iScience, 24 (1), 101881. doi:10.1016/j.isci.2020.101881
Peer Reviewed verified by ORBi

Plum, P.-E., Darcis, G., & Moutschen, M. (2021). L’arrivée des bithérapies dans le traitement du virus de l’immunodéficience humaine : la fin d’un dogme? Revue Médicale de Liège, 76 (9), 677 - 682.
Editorial Reviewed verified by ORBi

Ngongo, N. M., Darcis, G., Nanituna, H. S., Mambimbi, M. M., Maes, N., Mashi, M. L., Bepouka Izizag, B., Moutschen, M., & Lepira Bompeka, F. (2021). Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017. PLoS ONE, 16 (11), 0259073. doi:10.1371/journal.pone.0259073
Peer Reviewed verified by ORBi

Ngongo, N. M., Nani-Tuma, H. S., Mambimbi, M. M., Mashi, M. L., Izizag, B. B., Maes, N., Moutschen, M., & Darcis, G. (2021). Progressive phasing out of baseline CD4+ cell count testing for people living with HIV in Kinshasa, Democratic Republic of the Congo. AIDS (London, England), 35 (5), 841-843. doi:10.1097/QAD.0000000000002802
Peer reviewed

Meuris, C., Kremer, C., Geerinck, A., Locquet, M., Bruyère, O., Defêche, J., Meex, C., Hayette, M.-P., Duchene, L., Dellot, P., Azarzar, S., Maréchal, N., Sauvage, A.-S., Frippiat, F., Giot, J.-B., Léonard, P., Fombellida, K., Moutschen, M., Durkin, K., ... Darcis, G. (2021). Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium. JAMA Network Open, 4 (10), 2128757. doi:10.1001/jamanetworkopen.2021.28757
Peer Reviewed verified by ORBi

Chatterjee, A., Wu, G., Primakov, S., Oberije, C., Woodruff, H., Kubben, P., Henry, R., Aries, M. J. H., Beudel, M., Noordzij, P. G., Dormans, T., Gritters van den Oever, N. C., van den Bergh, J. P., Wyers, C. E., Simsek, S., Douma, R., Reidinga, A. C., de Kruif, M. D., GUIOT, J., ... Lambin, P. (2021). Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study. PLoS ONE, 16 (4), 0249920. doi:10.1371/journal.pone.0249920
Peer Reviewed verified by ORBi

Defêche, J., AZARZAR, S., Mesdagh, A., DELLOT, P., Tytgat, A., Bureau, F., Gillet, L., Belhadj, Y., BONTEMS, S., HAYETTE, M.-P., Schils, R., Rahmouni, S., ERNST, M., MOUTSCHEN, M., & DARCIS, G. (2021). In-Depth Longitudinal Comparison of Clinical Specimens to Detect SARS-CoV-2. Pathogens (Basel, Switzerland), 10 (11). doi:10.3390/pathogens10111362
Peer reviewed

GUIOT, J., Vaidyanathan, A., DEPREZ, L., Zerka, F., Danthine, D., Frix, A.-N., THYS, M., HENKET, M., CANIVET, G., Mathieu, S., EFTAXIA, E., Lambin, P., Tsoutzidis, N., Miraglio, B., Walsh, S., Moutschen, M., Louis, R., Meunier, P., Vos, W., ... LOVINFOSSE, P. (2021). Development and Validation of an Automated Radiomic CT Signature for Detecting COVID-19. Diagnostics, 11 (1). doi:10.3390/diagnostics11010041
Peer reviewed

LAMBERMONT, B., SEIDEL, L., THYS, M., CAVALLERI, J., DELANAYE, P., CANIVET, J.-L., KISOKA, G., LAYIOS, N., LEDOUX, D., MASSION, P., MORIMONT, P., Parzibut, G., PIRET, S., ROBINET, S., ROUSSEAU, A.-F., WIESEN, P., Chase, J. G., MEURIS, C., Moutschen, M., & Misset, B. (2021). Comparison of Covid-19 patient management and outcome in a tertiary care center during the first and second waves of the pandemic. Annals of Intensive Care, Suppl 1, 86.
Peer Reviewed verified by ORBi

D'Antonio, M., Nguyen, J. P., Arthur, T. D., Matsui, H., COVID-19 Host Genetics Initiative, D'Antonio-Chronowska, A., Frazer, K. A., & Moutschen, M. (Other coll.). (2021). SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues. Cell Reports, 37 (7), 110020. doi:10.1016/j.celrep.2021.110020
Peer Reviewed verified by ORBi

Darcis, G., Bouquegneau, A., Maes, N., Thys, M., Henket, M., Labye, F., Rousseau, A.-F., Canivet, P., Desir, C., Calmes, D., Schils, R., De Worm, S., Léonard, P., Meunier, P., Moutschen, M., Louis, R., & Guiot, J. (2021). Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study. International Journal of Infectious Diseases, 109, 209-216. doi:10.1016/j.ijid.2021.07.016
Peer reviewed

Ngongo, N. M., Nani-Tuma, H. S., Mambimbi, M. M., Mashi, M. L., Izizag, B. B., Ndolumingu, F. K., Maes, N., Moutschen, M., & Darcis, G. (2021). Decrease in late presentation for HIV care in Kinshasa, DRC, 2006-2020. AIDS Research and Therapy, 18 (1), 41. doi:10.1186/s12981-021-00366-8
Peer Reviewed verified by ORBi

CALMES, D., Graff, S., MAES, N., Frix, A.-N., THYS, M., BONHOMME, O., Berg, J., DEBRUCHE, M., GESTER, F., HENKET, M., PAULUS, V., DUYSINX, B., HEINEN, V., NGUYEN DANG, D., PAULUS, A., QUAEDVLIEG, V., VAILLANT, F., VAN CAUWENBERGE, H., MALAISE, M., ... SCHLEICH, F. (2021). Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection. Journal of Allergy and Clinical Immunology: In Practice, 9 (1), 160-169. doi:10.1016/j.jaip.2020.09.044
Peer Reviewed verified by ORBi

Misset, B., Hoste, E., Donneau, A.-F., Grimaldi, D., Meyfroidt, G., Moutschen, M., Compernolle, V., Gothot, A., Desmecht, D., Garigliany, M.-M., Najdovski, T., & Laterre, P. F. (2021). Correction to: A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation: the CONFIDENT trial protocol (BMC Pulmonary Medicine, (2020), 20, 1, (317), 10.1186/s12890-020-01361-x). BMC Pulmonary Medicine, 21 (1). doi:10.1186/s12890-021-01574-8
Peer Reviewed verified by ORBi

Frix, A.-N., Schoneveld, L., LADANG, A., HENKET, M., DUYSINX, B., VAILLANT, F., Misset, B., Moutschen, M., Louis, R., Cavalier, E., & Guiot, J. (November 2020). Could KL-6 levels in COVID-19 help to predict lung disease? Respiratory Research, 21 (309). doi:10.1186/s12931-020-01560-4
Peer Reviewed verified by ORBi

Fombellida-Lopez, C., Chaslain, A., SUSIN, F., VAIRA, D., Moutschen, M., & DARCIS, G. (September 2020). Obstacles à la guérison de l'infection par le VIH. Partie 1 : les réservoirs latents. Revue Médicale de Liège, 75 (9), 573-577.
Peer reviewed

Chaslain, A., Fombellida-Lopez, C., SUSIN, F., VAIRA, D., Moutschen, M., & Darcis, G. (September 2020). Obstacles à la guérison de l'infection par le VIH. Partie 2 : la réplication continue malgré le traitement. Revue Médicale de Liège, 75 (9), 582-587.
Peer reviewed

DARCIS, G., VAIRA, D., & MOUTSCHEN, M. (2020). Impact of coronavirus pandemic and containment measures on HIV diagnosis. Epidemiology and Infection. doi:10.1017/S0950268820001867
Peer reviewed

PIRARD, C., Léonard, P., Plum, P.-E., Struvay, S., & Moutschen, M. (2020). Les dérivés combinés de l'artémisinine : une avancée thérapeutique dans le contrôle du paludisme non compliqué à Plasmodium falciparum. Revue Médicale de Liège, 75 (5-6), 362 - 365.
Editorial Reviewed verified by ORBi

GUIOT, J., HENKET, M., Frix, A.-N., Delvaux, M., DENIS, A., GILTAY, L., THYS, M., GESTER, F., MOUTSCHEN, M., CORHAY, J.-L., LOUIS, R., LAMBERMONT, B. (Other coll.), & MALAISE, O. (Other coll.). (2020). Single-center experience of patients with interstitial lung diseases during the early days of te COVID-19 pandemic. Respiratory Investigation, 58 (6), 437-9. doi:10.1016/j.resinv.2020.08.006
Peer Reviewed verified by ORBi

Ilbert, C., SABATIELLO, M., KURTH, W., Longrée, L., MOUTSCHEN, M., & DARCIS, G. (2020). Le syndrome de Schnitzler. Revue Médicale de Liège.
Peer reviewed

Scheen, A., & Moutschen, M. (2020). Le point sur les stratégies médicamenteuses contre la COVID-19 : entre espoirs et déceptions. Revue Médicale de Liège, 75 (S1), 162-169.
Peer reviewed

Wu, G., Yang, P., Xie, Y., Woodruff, H. C., Rao, X., Guiot, J., Frix, A.-N., Louis, R., Moutschen, M., Li, J., Li, J., Yan, C., Du, D., Zhao, S., Ding, Y., Liu, B., Sun, W., Albarello, F., D'Abramo, A., ... Lambin, P. (2020). Development of a Clinical Decision Support System for Severity Risk Prediction and Triage of COVID-19 Patients at Hospital Admission: an International Multicenter Study. European Respiratory Journal. doi:10.1183/13993003.01104-2020
Peer Reviewed verified by ORBi

Misset, B., Hoste, E., Donneau, A.-F., Grimaldi, D., Meyfroidt, G., MOUTSCHEN, M., Compernolle, V., GOTHOT, A., Desmecht, D., Garigliany, M.-M., Najdovski, T., & Laterre, P.-F. (2020). A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation: the CONFIDENT trial protocol. BMC Pulmonary Medicine. doi:10.1186/s12890-020-01361-x
Peer Reviewed verified by ORBi

Devos, T., Geukens, T., Schauwvlieghe, A., Ariën, K. K., Barbezange, C., Cleeren, M., Compernolle, V., Dauby, N., Desmecht, D., Grimaldi, D., Lambrecht, B. N., Luyten, A., Maes, P., Moutschen, M., Romano, M., Seyler, L., Nevessignsky, M. T., Vandenberghe, K., van Griensven, J., ... Meyfroidt, G. (2020). A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial. Trials, 21 (1), 981. doi:10.1186/s13063-020-04876-0
Peer Reviewed verified by ORBi

El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., Fombellida, K., VAIRA, D., Vercheval, C., Moutschen, M., & Darcis, G. (2020). Evolution of Drug Interactions With Antiretroviral Medication in People With HIV. Open Forum Infectious Diseases, 7 (11), 416. doi:10.1093/ofid/ofaa416
Peer Reviewed verified by ORBi

Mina, M., MOUTSCHEN, M., & MEURIS, C. (13 December 2019). Clinical case : chronic granulomatous disease [Paper presentation]. Annual Congress of the Belgian Society of Internal Medicine, Bruxelles, Belgium.
Peer reviewed

Mina, M., MOUTSCHEN, M., & MEURIS, C. (13 December 2019). Clinical case : chronic granulomatous disease [Paper presentation]. Annual Congress of the Belgian Society of Internal Medicine, Bruxelles, Belgium.
Peer reviewed

El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., FOMBELLIDA, K., VAIRA, D., Vercheval, C., MOUTSCHEN, M., & DARCIS, G. (22 November 2019). Evolution of drug interactions with antiretroviral medications in HIV-infected patients [Poster presentation]. 8th BREACH SYMPOSIUM, Liège, Belgium.

El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., Fombellida, K., VAIRA, D., Vercheval, C., MOUTSCHEN, M., & DARCIS, G. (08 November 2019). Evolution of drug interactions with antiretroviral medications in HIV-infected patients [Paper presentation]. 17th European AIDS Conference, Bâle, Switzerland.

Eron, J. J., Orkin, C., Cunningham, D., Pulido, F., Post, F. A., De Wit, S., Lathouwers, E., Hufkens, V., Jezorwski, J., Petrovic, R., Brown, K., Van Landuyt, E., Opsomer, M., EMERALD study group, & Moutschen, M. (Other coll.). (2019). Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1. Antiviral Research, 170, 104543. doi:10.1016/j.antiviral.2019.104543
Peer Reviewed verified by ORBi

DARCIS, G., MAES, N., Pasternak, A., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., El Moussaoui, M., Fombellida, K., VAIRA, D.* , & MOUTSCHEN, M.*. (2019). Detectability of HIV residual Viremia despite therapy is highly associated with treatment with a protease inhibitor-based combination antiretroviral therapy. Antimicrobial Agents and Chemotherapy. doi:10.1128/AAC.01902-19
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Pirotte, B., FRIPPIAT, F., DARCIS, G., Rassenfosse, M., Fombellida, K., MAES, N., Moerman, F., & MOUTSCHEN, M. (2019). Etude des motifs d'admission au service des Urgences d'une cohorte de patients. Revue Médicale de Liège.
Peer reviewed

Farhat, K., Bodart, G., Moutschen, M., Salvatori, R., Martens, H., & Geenen, V. (December 2018). Growth hormone (GH) deficient mice with GHRH ablation are severely deficient in vaccine and immune responses against Streptococcus pneumoniae. Acta Clinica Belgica, 73 (6 (Suppl.2)).
Peer Reviewed verified by ORBi

Farhat, K., Bodart, G., Charlet-Renard, J. D. C., Desmet, C., Moutschen, M., Beguin, Y., Baron, F., Melin, P., Quatresooz, P., Parent, A.-S., Desmecht, D., Sirard, J.-C., Salvatori, R., Martens, H., & Geenen, V. (02 October 2018). Growth hormone (GH) deficient mice with GHRH ablation are severely deficient in vaccine and immune responses against Streptococcus pneumoniae. Frontiers in Immunology, 9, 2175. doi:10.3389/fimmu.2018.02175
Peer Reviewed verified by ORBi

DARCIS, G., Lambert, I., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., GIOT, J.-B., fombellida, K., VAIRA, D., & MOUTSCHEN, M. (2018). Factors associated with late presentation for HIV care in a single Belgian reference center: 2006-2017. Scientific Reports. doi:10.1038/s41598-018-26852-0
Peer Reviewed verified by ORBi

Farhat, K., Bodart, G., Desmet, C., Moutschen, M., Beguin, Y., Baron, F., Salvatori, R., Martens, H., & Geenen, V. (20 March 2018). GHRH-deleted Mice Are Severely Deficient in Vaccine And Immunological Responses Against Streptococcus Pneumoniae [Paper presentation]. ENDO 2018, Chicago, United States.

Egg, D., Schwab, C., Gabrysch, A., Arkwright, P. D., Cheesman, E., Giulino-Roth, L., Neth, O., Snapper, S., Okada, S., Moutschen, M., Delvenne, P., Pecher, A.-C., Wolff, D., Kim, Y.-J., Seneviratne, S., Kim, K.-M., Kang, J.-M., Ojaimi, S., McLean, C., ... Grimbacher, B. (2018). Increased risk for malignancies in 131 affected CTLA4 mutation carriers. Frontiers in Immunology, 9 (SEP). doi:10.3389/fimmu.2018.02012
Peer Reviewed verified by ORBi

De Wit, S., Florence, E., Vandekerckhove, L., Vandercam, B., Goffard, J.-C., Van Wijngaerden, E., Moutschen, M., Demeester, R., Thilakarathne, P., Piryns, H., & for the BREACH* Consortium. (2018). Long-term use of darunavir/ritonavir-containing regimens in daily practice in Belgium: retrospective observational cohort data of 1701 HIV-patients. Acta Clinica Belgica, 1-7. doi:10.1080/17843286.2018.1458428
Peer Reviewed verified by ORBi

de Worm, S., GIOT, J.-B., Courtoy, C., Gillet, E., Amrane, S., Huynen, P., Van Esbroeck, M., Prudent, E., Lepidi, H., Million, M., Moutschen, M., & Raoult, D. (2018). A case of giant cell arteritis associated with culture-proven Coxiella burnetii aortitis. International Journal of Infectious Diseases, 69, 50-54. doi:10.1016/j.ijid.2018.01.028
Peer Reviewed verified by ORBi

Schwab, C., Gabrysch, A., Olbrich, P., Patino, V., Warnatz, K., Wolff, D., Hoshino, A., Kobayashi, M., Imai, K., Takagi, M., Dybedal, I., Haddock, J. A., Sansom, D. M., Lucena, J. M., Seidl, M., Schmitt-Graeff, A., Reiser, V., Emmerich, F., Frede, N., ... Grimbacher, B. (2018). Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects. Journal of Allergy and Clinical Immunology, 142 (6), 1932-1946. doi:10.1016/j.jaci.2018.02.055
Peer Reviewed verified by ORBi

De Benedetti, F., Gattorno, M., Anton, J., Ben-Chetrit, E., Frenkel, J., Hoffman, H. M., Kone-Paut, I., Lachmann, H. J., Ozen, S., Simon, A., Zeft, A., Calvo Penades, I., Moutschen, M., Quartier, P., Kasapcopur, O., Shcherbina, A., Hofer, M., Hashkes, P. J., Van der Hilst, J., ... Junge, G. (2018). Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes. New England Journal of Medicine, 378 (20), 1908-1919. doi:10.1056/NEJMoa1706314
Peer Reviewed verified by ORBi

Calderaro, J., Letouze, E., Bayard, Q., Boulai, A., Renault, V., Deleuze, J.-F., Bestard, O., Franco, D., Zafrani, E.-S., Nault, J.-C., Moutschen, M., & Zucman-Rossi, J. (2018). Systemic AA Amyloidosis Caused by Inflammatory Hepatocellular Adenoma. New England Journal of Medicine, 379 (12), 1178-1180. doi:10.1056/NEJMc1805673
Peer Reviewed verified by ORBi

DARCIS, G., & Moutschen, M. (2018). Wild-type HIV infection despite PrEP: a lot to learn from a case report. The Lancet HIV, 5 (1), 10. doi:10.1016/S2352-3018(17)30212-6
Peer Reviewed verified by ORBi

Moutschen, M., Martens, H., & Geenen, V. (2017). Immunosenescence and infectious diseases. In J.-P. Michel, B. L. Beattie, F. C. Martin, ... J. D. Walston (Eds.), Oxford Textbook of Geriatric Medicine - 3rd Edition (10.1093/med/9780198701590.001.0001, pp. 1-17). Oxford, United Kingdom: Oxford University Press. doi:10.1093/med/9780198701590.003.0079
Peer reviewed

DE VOEGHT, A., Martens, H., RENARD, J. D. C., VAIRA, D., Debruche, M., Simonet, J., Geenen, V., MOUTSCHEN, M., & DARCIS, G. (2017). Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium. PLoS ONE. doi:10.1371/journal.pone.0185761
Peer Reviewed verified by ORBi

Vandereyken, M., Jacques, S., Van Overmeire, E., Amand, M., Rocks, N., Delierneux, C., Singh, P., Singh, M., GHUYSEN, C., Wathieu, C., Zurashvili, T., Sounni, N. E., Moutschen, M., Gilles, C., Oury, C., Cataldo, D., Van Ginderachter, J. A., & Rahmouni, S. (2017). Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner. PLoS ONE. doi:10.1371/journal.pone.0185786
Peer Reviewed verified by ORBi

DARCIS, G., Van der Auwera, G., GIOT, J.-B., Hayette, M.-P., Tassin, F., Arrese Estrada, J., Cnops, L., Moutschen, M., de Leval, L., & LEONARD, P. (07 July 2017). Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy. BMC Infectious Diseases, 17. doi:10.1186/s12879-017-2571-x
Peer Reviewed verified by ORBi

Farhat, K., Bodart, G., RENARD, J. D. C., Desmet, C., MOUTSCHEN, M., Beguin, Y., Baron, F., Salvatori, R., Geenen, V., & Martens, H. (23 May 2017). A surprising and dramatic neuroendocrine-immune phenotype of mice deficient in Growth Hormone-Releasing Hormone (GHRH) [Poster presentation]. European Congress of Endocrinology, Lisbonne, Portugal. doi:10.1530/endoabs.49.EP883

Farhat, K., Bodart, G., Renard, C., Desmet, C., MOUTSCHEN, M., BARON, F., Beguin, Y., Salvatori, R., Martens, H., & GEENEN, V. (May 2017). A surprising and dramatic neuroendocrine-immune phenotype of mice deficient in Growth Hormone-Releasing Hormone (GHRH) [Poster presentation]. The 19th European Congress of Endocrinology, Lisbon, Portugal.

HUART, J., GROSCH, S., BOVY, C., Moutschen, M., & Krzesinski, J.-M. (April 2017). IgG4-related membranous glomerulonephritis and generalized lymphadenopathy without pancreatitis: a case report. BMC Nephrology, 18, 139. doi:10.1186/s12882-017-0561-2
Peer Reviewed verified by ORBi

DARCIS, G., & Moutschen, M. (2017). Guérir l'infection par le VIH: Un objectif réaliste? Revue Médicale de Liège, 72 (9), 388-392.
Peer reviewed

BRULS, S., Courtois, A., DELVENNE, P., HUSTINX, R., MOUTSCHEN, M., de Leval, L., Defraigne, J.-O., & SAKALIHASAN, N. (2017). IgG4-related disease causing rapid evolution of a severe aortic valvular stenosis. Annals of Thoracic Surgery. doi:10.1016/j.athoracsur.2016.08.045
Peer Reviewed verified by ORBi

Farhat, K., Bodart, G., Martens, H., Baron, F., Beguin, Y., Moutschen, M., Salvatori, R., & Geenen, V. (2017). A surprising and dramatic neuroendocrine-immune phenotype of mice deficient in Growth Hormone-Releasing Hormone (GHRH). Neuroimmunomodulation.
Peer Reviewed verified by ORBi

Adawaye, C., Fokam, J., Kamangu, E., Alio, H. M., Chahad, A. M., SUSIN, F., Moussa, A. M., Bertin, T. H. Z., Tidjani, A., VAIRA, D., & Moutschen, M. (2017). Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N'Djamena, Chad: Findings from a cross-sectional study. BMC Research Notes, 10 (1). doi:10.1186/s13104-017-2893-1
Peer Reviewed verified by ORBi

Gunter, J., Callens, S., De Wit, S., Goffard, J.-C., Moutschen, M., DARCIS, G., MEURIS, C., van den Bulcke, C., Fombellida, K., del Forge, M., Razavi, H., & Wyndham-Thomas, C. (2017). Prevalence of non-infectious comorbidities in the HIV-positive population in Belgium: a multicenter, retrospective study. Acta Clinica Belgica, 1-4. doi:10.1080/17843286.2017.1339965
Peer Reviewed verified by ORBi

Mukeba-Tshialala, D., Nachega, J. B., Mutombo-Tshingwali, M., Arendt, V., Gilson, G., & Moutschen, M. (2017). Obésité, hypertension artérielle, hypercholestérolémie et diabète non traités chez les adultes infectés ou pas par le VIH à Mbuji-Mayi (République démocratique du Congo). Bulletin de la Société de Pathologie Exotique, 110 (5), 301-309. doi:10.1007/s13149-017-0561-2
Peer Reviewed verified by ORBi

Deleixhe, B., FRIPPIAT, F., Léonard, P., WITHOFS, N., MEEX, C., Pierard, L., & Moutschen, M. (2017). Endocardite à aggregatibacter aphrophilus sur prothèses valvulaires. Revue Médicale de Liège, 72 (12), 522-528.
Peer reviewed

Narinx, J., Poncin, A., HUYNEN, P., Moutschen, M., & GIOT, J.-B. (2017). Atteinte hépato-splénique et bartonellose systémique chez une patiente immunocompétente. Revue Médicale de Liège, 72 (7-8), 331-335.
Peer reviewed

Vandereyken, M., Singh, P., Wathieu, C., Jacques, S., Zurashvili, T., Dejager, L., Amand, M., Musumeci, L., Singh, M., MOUTSCHEN, M., Libert, C., & Rahmouni, S. (2017). Dual-Specificity Phosphatase Deletion Protects Female, but Not Male, Mice from Endotoxemia- and Polymicrobial-Induced Septic Shock. Journal of Immunology. doi:10.4049/jimmunol.1602092
Peer Reviewed verified by ORBi

Mayaki, Z., Seydou, M., Moutschen, M., Albert, A., Dardenne, N., Sondag, D., Gossens, D., & Gérard, C. (2017). Rapid tests and transfusion safety in Niamey, Niger. Médecine et Santé Tropicales, 27 (1), 95-100. doi:10.1684/mst.2017.0663
Peer Reviewed verified by ORBi

Vogl, C., Butola, T., Haag, N., Hausrat, T. J., Leitner, M. G., Moutschen, M., Lefèbvre, P., Speckmann, C., Garrett, L., Becker, L., Fuchs, H., Hrabe de Angelis, M., Nietzsche, S., Kessels, M., Oliver, D., Kneussel, M., Kilimann, M. W., & Strenzke, N. (2017). The BEACH protein LRBA is required for hair bundle maintenance in cochlear hair cells and for hearing. EMBO Reports, 18 (11), 2015-2029. doi:10.15252/embr.201643689
Peer Reviewed verified by ORBi

DARCIS, G., & Moutschen, M. (2017). The effect of treatment simplification on HIV reservoirs. The Lancet HIV, 4 (8), 328-e329. doi:10.1016/S2352-3018(17)30135-2
Peer Reviewed verified by ORBi

Jacques, S., Arjomand, A., Vandereyken, M., Moutschen, M., Oury, C., & Rahmouni, S. (08 December 2016). DUSP3 genetic deletion predispose to obesity-induced hepatocellular carcinoma [Poster presentation]. Séminaire des chercheurs Télévie, Louvain, Belgium.

Farhat, K., Bodart, G., Desmet, C., Moutschen, M., Salvatori, R., Geenen, V., & Martens, H. (07 November 2016). Severe deficiency of the somatotrope GHRH/GH/IGF-1 axis induces a dramatic susceptibility to Streptococcus pneumoniae infection [Poster presentation]. Growth Hormone Research Society (GRS) and IGF Society, Tel Aviv, Israel.

Farhat, K., Bodart, G., RENARD, J. D. C., Desmet, C., Moutschen, M., Baron, F., Beguin, Y., Salvatori, R., Geenen, V., & Martens, H. (November 2016). Severe deficiency of the somatotrope GHRH/GH/IGF1 axis induces a dramatic susceptibility to Streptococcus pneumoniae infection [Paper presentation]. 50e Congrès de la Société Française d'Immunologie (SFI), Paris, France.

DE VOEGHT, A., Maes, N., & Moutschen, M. (27 March 2016). sCD14 is not a bona-fide biomarker of microbial translocation in HIV-1 infected Africans living in Belgium. AIDS, 30 (6), 921-4. doi:10.1097/QAD.0000000000000996
Peer Reviewed verified by ORBi

DE VOEGHT, A., SAUVAGE, A.-S., GENSBURGER, M., GIOT, J.-B., & Moutschen, M. (2016). Tuberculose miliaire chez une patiente sous adalimumab. Revue Médicale de Liège, 71 (7-8), 328-331.
Peer reviewed

Mayaki, Z., Kabo, R., Moutschen, M., Albert, A., Dardenne, N., Sondag, D., & Gérard, C. (2016). Knowledge, attitudes and clinical practice of blood products prescribers in Niamey. Transfusion Clinique et Biologique, 23 (2), 78-85. doi:10.1016/j.tracli.2015.11.007

Moutschen, M. (2016). Prevenar 13®, un vaccin conjugué anti-pneumococcique pour la prévention des infections à pneumocoque chez les adultes à risque. Revue Médicale de Liège, 71 (4), 204-209.
Peer reviewed

Durel, C.-A., Aouba, A., Bienvenu, B., Deshayes, S., Coppere, B., Gombert, B., Acquaviva-Bourdain, C., Hachulla, E., Lecomte, F., Touitou, I., Ninet, J., Philit, J.-B., Messer, L., Brouillard, M., Girard-Madoux, M.-H., Moutschen, M., Raison-Peyron, N., Hutin, P., Duffau, P., ... Hot, A. (2016). Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency. Medicine, 95 (11), 3027. doi:10.1097/MD.0000000000003027
Peer Reviewed verified by ORBi

van der Hilst, J. C., Moutschen, M., Messiaen, P. E., Lauwerys, B. R., & Vanderschueren, S. (2016). Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature. Biologics: Targets and Therapy, 10, 75-80. doi:10.2147/BTT.S102954
Peer Reviewed verified by ORBi

SAUVAGE, A.-S., DARCIS, G., & Moutschen, M. (2016). Actualité thérapeutique dans le VIH: Le ténofovir alafénamide. Revue Médicale Suisse, 12 (527), 1367-1369.
Peer Reviewed verified by ORBi

MALAISE, O., CHAUVEHEID, F., VON FRENCKELL, C., LEONARD, P., MOUTSCHEN, M., DEMONTY, J., & MALAISE, M. (September 2015). Newly diagnosed adult onset Still’s disease between 2002 and 2014: retrospective clinical biological and therapeutic characterization. Comparison with 1988 – 2001 data [Poster presentation]. Belgian congress of Rheumatology 2015.
Peer reviewed

Vandereyken, M., Amand, M., Van Overmeire, E., Zurashvili, T., MOUTSCHEN, M., Gilles, C., Van Ginderachter, J., & Rahmouni, S. (June 2015). Genetic depletion of the dual specificity protein phosphatase DUSP3 promotes LLC Lung tumour metastasis [Paper presentation]. Europhosphatase 2015: Phosphorylation switches and cellular homeostasis, Turku, Finland.

Vandereyken, M., Amand, M., Van Overmeire, E., Zurashvili, T., MOUTSCHEN, M., Noël, A., Gilles, C., Van Ginderachter, J., & Rahmouni, S. (June 2015). Genetic depletion of the dual specificity protein phosphatase DUSP3 promotes LLC Lung tumour metastasis [Poster presentation]. Europhosphatase 2015: Phosphorylation switches and cellular homeostasis, Turku, Finland.

Singh, P.* , Dejager, L.* , Amand, M.* , Theatre, E., Vandereyken, M., Zurashvili, T., Singh, M., Mack, M., Timmermans, S., Musumeci, L., Dejardin, E., Mustelin, T., Van Ginderachter, J. A., Moutschen, M., Oury, C., Libert, C., & Rahmouni, S. (15 May 2015). DUSP3 genetic deletion confers M2-like−macrophage-dependent tolerance to septic shock. Journal of Immunology, 194 (10), 4951-62. doi:10.4049/jimmunol.1402431
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Belche, J. L., Kang, T., Ketterer, F., Berrewaerts, M.-A., MOUTSCHEN, M., & Giet, D. (May 2015). L’infection par le VIH : une maladie chronique redéfinissant la collaboration entre généralistes et spécialistes. Obstacles et opportunités. Santé Publique: Revue Multidisciplinaire pour la Recherche et l'Action, 27 (3/2015), 373-381. doi:10.3917/spub.153.0373
Peer Reviewed verified by ORBi

STERGIOPOULOU, T., Walsh, T. J., SEGHAYE, M.-C., Netea, M. G., Casanova, J.-L., Moutschen, M., & PICARD, C. (March 2015). Deficiency of Interleukin-1 Receptor-associated Kinase 4 Presenting as Fatal Pseudomonas aeruginosa Bacteremia in Two Siblings. Pediatric Infectious Disease Journal, 34 (3), 299-300. doi:10.1097/INF.0000000000000550
Peer Reviewed verified by ORBi

Musumeci, L., Kuijpers, M., Gilio, K., Hego, A., Theatre, E., Maurissen, L., Vandereyken, M., Diogo, C., LECUT, C., Guilmain, W., Bobkova, E., Eble, J., Dahl, R., Drion, P., Rascon, J., Mostofi, Y., Yuan, H., Sergienko, E., Chung, T., ... Rahmouni, S.*. (17 February 2015). DUSP3 Phosphatase Deficiency or Inhibition Limit Platelet Activation and Arterial Thrombosis. Circulation, 131 (7), 656-68. doi:10.1161/CIRCULATIONAHA.114.010186
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Kouri, V., Khouri, R., Alemán, Y., Abrahantes, Y., Vercauteren, J., Pineda-Peña, A.-C., Theys, K., Megens, S., Moutschen, M., Pfeifer, N., Van Weyenbergh, J., Pérez, A. B., Pérez, J., Pérez, L., Van Laethem, K., & Vandamme, A.-M. (2015). CRF19_cpx is an Evolutionary fit HIV-1 Variant Strongly Associated With Rapid Progression to AIDS in Cuba. EBioMedicine, 2 (3), 244-254. doi:10.1016/j.ebiom.2015.01.015
Peer Reviewed verified by ORBi

Van Beckhoven, D., Florence, E., Ruelle, J., Deblonde, J., Verhofstede, C., Callens, S., Vancutsem, E., Lacor, P., Demeester, R., Goffard, J.-C., Sasse, A., De Wit, S., Vogelaers, D., Delforge, M.-L., Florence, E., Fransen, K., Goffard, J.-C., Hayette, M.-P., Lacor, P., ... Verhofstede, C. (2015). Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants. BMC Infectious Diseases, 15 (1). doi:10.1186/s12879-015-1230-3
Peer Reviewed verified by ORBi

DARCIS, G., Kula, A., Bouchat, S., Fujinaga, K., Corazza, F., Ait-Ammar, A., Delacourt, N., Melard, A., Kabeya, K., Vanhulle, C., Van Driessche, B., GATOT, J.-S., Cherrier, T., Pianowski, L. F., Gama, L., Schwartz, C., Vila, J., Burny, A., Clumeck, N., ... Van Lint, C. (2015). An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression. PLoS Pathogens, 11 (7), 1005063. doi:10.1371/journal.ppat.1005063
Peer Reviewed verified by ORBi

Lantto, R., Nasi, A., Sammicheli, S., Amu, S., Fievez, V., Moutschen, M., Pensieroso, S., Hejdeman, B., Chiodi, F., & Rethi, B. (2015). Increased extrafollicular expression of the B-cell stimulatory molecule CD70 in HIV-1-infected individuals. AIDS, 29 (14), 1757-1766. doi:10.1097/QAD.0000000000000779
Peer Reviewed verified by ORBi

Bruls, S.* , Courtois, A.* , Nusgens, B., Defraigne, J.-O., Delvenne, P., Hustinx, R., Moutschen, M., & SAKALIHASAN, N. (2015). 18F-FDG PET/CT in the Management of Aortitis. Clinical Nuclear Medicine. doi:10.1097/RLU.0000000000001016
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

FRIPPIAT, F., Musuamba, F. T., Seidel, L., Albert, A., DENOOZ, R., Charlier, C., Van Bambeke, F., Wallemacq, P., DESCY, J., LAMBERMONT, B., LAYIOS, N., DAMAS, P., & Moutschen, M. (12 September 2014). Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study. Journal of Antimicrobial Chemotherapy, 70, 207-216. doi:10.1093/jac/dku354
Peer Reviewed verified by ORBi

STERGIOPOULOU, T., Walsh, T. J., SEGHAYE, M.-C., Netea, M. G., Casanova, J.-L., MOUTSCHEN, M., & Picard, C. (09 May 2014). Primary deficiency of interleukin-1 receptor-associated kinase (IRAK-4) presenting as fatal pseudomonas aeruginosa bacteremia in two siblings [Poster presentation]. 32nd Annual Meeting of the European Society for Paediatric Infectious Diseases, Dublin, Ireland.

Singh, M., Singh, P., VAIRA, D., Torheim, E. A., Rahmouni, S., Tasken, K., & MOUTSCHEN, M. (February 2014). The RIAD peptidomimetic inhibits HIV-1 replication in humanized NSG mice. European Journal of Clinical Investigation, 44 (2), 146-152. doi:10.1111/eci.12200
Peer Reviewed verified by ORBi

Amand, M., Erpicum, C., BAJOU, K., Cerignoli, F., Blacher, S., MARTIN, M., Dequiedt, F., Drion, P., Singh, P., Vandereyken, M., Musumeci, L., Moutschen, M., Gilles, C., Noël, A., & Rahmouni, S. (27 January 2014). DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase [Poster presentation]. GIGA Day 2014, Liège, Belgium.

MILICEVIC, M., GROSCH, S., Krzesinski, J.-M., Moutschen, M., & BOVY, C. (22 January 2014). Un cas particulier d'amyloïdose AA [Paper presentation]. Confrontations anatomocliniques en pathologie rénale et vasculaire, Paris, France.

Megens, S., VAIRA, D., De Baets, G., Dekeersmaeker, N., Schrooten, Y., Li, G., Schymkowitz, J., Rousseau, F., Vandamme, A.-M., Moutschen, M., & Van Laethem, K. (2014). Horizontal gene transfer from human host to HIV-1 reverse transcriptase confers drug resistance and partly compensates for replication deficits. Virology, 456-457, 310-8. doi:10.1016/j.virol.2014.03.023
Peer Reviewed verified by ORBi

Amand, M., Erpicum, C., BAJOU, K., Cerignoli, F., Blacher, S., Martin, M., Dequiedt, F., Drion, P., Singh, P., Zurashvili, T., Vandereyken, M., Musumeci, L., Mustelin, T., Moutschen, M., Gilles, C., Noël, A., & Rahmouni, S. (2014). DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase. Molecular Cancer. doi:10.1186/1476-4598-13-108
Peer Reviewed verified by ORBi

Duray, A., Demoulin, S., Petermans, J., Moutschen, M., Saussez, S., Jerusalem, G., & Delvenne, P. (2014). Vieillissement et cancer: coincidence ou relation etiologique? Revue Médicale de Liège, 69 (5-6), 276-81.
Peer reviewed

Bonhomme, O., & Moutschen, M. (2014). Diagnostic et traitement des oedèmes angioneurotiques héréditaires: Illustration clinique et brève revue de la littérature. Revue Médicale de Liège, 69 (10), 541 - 548.
Editorial Reviewed verified by ORBi

Torres, A., Bonanni, P., Hryniewicz, W., Moutschen, M., Reinert, R. R., & Welte, T. (2014). Pneumococcal vaccination: what have we learnt so far and what can we expect in the future? European Journal of Clinical Microbiology and Infectious Diseases. doi:10.1007/s10096-014-2208-6
Peer Reviewed verified by ORBi

Singh, M., Singh, P., VAIRA, D., Amand, M., Rahmouni, S., & Moutschen, M. (2014). Minocycline attenuates HIV-1 infection and suppresses chronic immune activation in humanized NOD/LtsZ-scidIL-2Rgamma(null) mice. Immunology, 142 (4), 562-72. doi:10.1111/imm.12246
Peer Reviewed verified by ORBi

Frippiat, F., Seidel, L., Denooz, R., DAMAS, P., Layios, N., & Moutschen, M. (2014). Pharmacokinetics of Extended vs Intermittent Intravenous Infusion of Meropenem in Critically Ill Patients Receiving Continuous Veno-Venous Haemofiltration. Open Forum Infectious Diseases. doi:10.1093/ofid/ofu052
Peer Reviewed verified by ORBi

LAYIOS, N., CANIVET, J.-L., Baron, F., Moutschen, M., & Hayette, M.-P. (2014). Mortierella wolfii-Associated Invasive Disease. Emerging Infectious Diseases, 20 (9), 1591-2. doi:10.3201/eid2009.140469
Peer Reviewed verified by ORBi

DARCIS, G., Kula, A., Bouchat, S., Kabeya, K., Delacourt, N., Vanhulle, C., GATOT, J.-S., VAIRA, D., Burny, A., Clumeck, N., Rohr, O., MOUTSCHEN, M., Corrazza, F., Rouzioux, C., De Wit, S., & Van Lint, C. (2014). Synergistic activation of HIV-1 expression by compounds targeting the positive transcription elongation factor b (P-TEFb) and by inducers of the NF-kB signaling pathway [Paper presentation]. 20th AIDS international conference, Melbourne, Australia.

ESSER, N., L'Homme, L., DE ROOVER, A., KOHNEN, L., SCHEEN, A., MOUTSCHEN, M., Piette, J., Legrand-Poels, S., & PAQUOT, N. (November 2013). Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue. Diabetologia, 56, 2487-2497. doi:10.1007/s00125-013-3023-9
Peer Reviewed verified by ORBi

Adawaye, C. I., Erick, K., Ali, M. M., Bertin, T., VAIRA, D., & MOUTSCHEN, M. (September 2013). Use of Dried Blood Spot to Improve the Diagnosis and Management of HIV in Resource-Limited Settings. World Journal of AIDS, 3, 251-256. doi:10.4236/WJA.2013.33033
Peer reviewed

LAYIOS, N., HAYETTE, M.-P., HUWART, A., JOSKIN, J., BLETARD, N., BARON, F., & MOUTSCHEN, M. (September 2013). First report of Mortierella wolfii causing human disease [Poster presentation]. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).

LAYIOS, N., HAYETTE, M.-P., HUWART, A., JOSKIN, J., BLETARD, N., BARON, F., & MOUTSCHEN, M. (September 2013). First report of Mortierella wolfii causing human disease [Paper presentation]. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).

Musumeci, L., Maurissen, L., Kuijpers, M. J., Senis, Y., MOUTSCHEN, M., Mustelin, T., Heemskerk, J. W., Oury, C., & Rahmouni, S. (02 July 2013). Genetic deletion of Vaccinia H1-related (VHR) phosphatase inhibits collagen-induced platelet activation and thrombus formation without affecting bleeding time in mice [Paper presentation]. XXIVth Congress of the ISTH, Amsterdam, Netherlands.

Esser, N., L'Homme, L., DE ROOVER, A., KOHNEN, L., SCHEEN, A., MOUTSCHEN, M., Piette, J., Legrand-Poels, S., & PAQUOT, N. (2013). Increased Inflammasome and Caspase-1 Activation in Visceral adipose tissue from Metabolically Unhealthy Obese compared to Metabolically Healthy Obese subjects. Diabetes, (62/suppl.1), 555.
Peer Reviewed verified by ORBi

Rahmouni, S., Singh, P., Dejager, L., Singh, M., Amand, M., Musumeci, L., Moutschen, M., Mustelin, T., & Libert, C. (2013). Dual-specificity phosphatase 3 knockout female mice are resistant to LPS and to polymicrobial induced septic shock in TNF dependent manner. Journal of Immunology.
Peer Reviewed verified by ORBi

Esser, N., L'Homme, L., DE ROOVER, A., KOHNEN, L., SCHEEN, A., Moutschen, M., Piette, J., Legrand-Poels, S., & PAQUOT, N. (March 2013). Différences d’activité de l’inflammasome NLRP3 entre sujets obèses avec et sans anomalies métaboliques. Diabetes and Metabolism, 39 (suppl 1), 102.
Peer Reviewed verified by ORBi

Esser, N., L'Homme, L., SCHEEN, A., MOUTSCHEN, M., Piette, J., PAQUOT, N., & Legrand, S. (January 2013). Differences in inflammasome activation between metabolically healthy and unhealthy obese individuals [Poster presentation]. Metabolic control of inflammation and immunity, Breckenridge, Colorado, United States.

MAYAKI, Z., Dardenne, N., KAB0, R., Moutschen, M., Sondag, D., Albert, A., & GERARD, C. (2013). seroprevalence of infectious markers among blood donors in Niamey (Niger). Revue d'Épidémiologie et de Santé Publique, 61 (3), 233-240. doi:10.1016/j.respe.2012.12.018
Peer Reviewed verified by ORBi

Pirotte, B., Rassenfosse, M., Collin, R., De Voeght, A., MOUTSCHEN, M., & CAVALIER, E. (2013). Rôle de la vitamine D dans l'infection par le VIH: revue des connaissances actuelles. Revue Médicale de Liège, 68 (1), 25-31.
Peer reviewed

DARCIS, G., Kula, A., Bouchat, S., Kabeya, K., Delacourt, N., Vanhulle, C., GATOT, J.-S., VAIRA, D., Burny, A., Herbein, G., Clumeck, N., Rohr, O., MOUTSCHEN, M., Rouzioux, C., De Wit, S., & Van Lint, C. (2013). Synergistic activation of HIV-1 expression by compounds targeting the positive transcription elongation factor b (P-TEFb) and by inducers of the NF-B signaling pathway [Paper presentation]. 14th European AIDS Conference (EACS), Brussels.

DARCIS, G., Kula, A., Bouchat, S., Kabeya, K., Delacourt, N., Vanhulle, C., GATOT, J.-S., VAIRA, D., Burny, A., Herbein, G., Clumeck, N., Rohr, O., MOUTSCHEN, M., Rouzioux, C., De Wit, S., & Van Lint, C. (2013). Synergistic activation of HIV-1 expression by compounds targeting the positive transcription elongation factor b (P-TEFb) and by inducers of the NF-B signaling pathway [Paper presentation]. First annual meeting Belgian Society for Virology.

Lubangi, M., & MOUTSCHEN, M. (2012). Perceptions de la pratique des essais cliniques sur le VIH/sida par les médecins prescripteurs des antirétroviraux agréés de Kinshasa (RD Congo). Bulletin de la Société de Pathologie Exotique. doi:10.1007/s13149-012-0263-8
Peer Reviewed verified by ORBi

Moutschen, M., FRIPPIAT, F., CHRISTIAENS, G., & ALLEPAERTS, S. (14 June 2012). HYGIENE ET PROBLEMES INFECTIEUX EN GERIATRIE [Paper presentation]. SOIREES DU MASTER COMPLEMENTAIRE EN GERIATRIE, CHENEE (LIEGE), Belgium.

Lopez-Herrera, G., Tampella, G., Pan-Hammarstrom, Q., Herholz, P., Trujillo-Vargas, C. M., Phadwal, K., Simon, A. K., Moutschen, M., Etzioni, A., Mory, A., Srugo, I., Melamed, D., Hultenby, K., Liu, C., Baronio, M., Vitali, M., Philippet, P., DIDEBERG, V., Aghamohammadi, A., ... Grimbacher, B. (2012). Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. American Journal of Human Genetics, 90 (6), 986-1001. doi:10.1016/j.ajhg.2012.04.015
Peer Reviewed verified by ORBi

Theys, K., Deforche, K., Vercauteren, J., Libin, P., van de Vijver, D. A., Albert, J., Asjo, B., Balotta, C., Bruckova, M., Camacho, R. J., Clotet, B., Coughlan, S., Grossman, Z., Hamouda, O., Horban, A., Korn, K., Kostrikis, L. G., Kucherer, C., Nielsen, C., ... MOUTSCHEN, M. (2012). Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients. Retrovirology, 9, 81. doi:10.1186/1742-4690-9-81
Peer Reviewed verified by ORBi

Crook, D. W., Walker, A. S., Kean, Y., Weiss, K., Cornely, O. A., Miller, M. A., Esposito, R., Louie, T. J., Stoesser, N. E., Young, B. C., Angus, B. J., Gorbach, S. L., Peto, T. E. A., & MOUTSCHEN, M. (Other coll.). (2012). Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials. Clinical Infectious Diseases, 55 Suppl 2, 93-103. doi:10.1093/cid/cis499
Peer Reviewed verified by ORBi

MOUTSCHEN, M. (2012). Gentetics, environment and determinants of autoimmune diseases. Revue Médicale de Liège, 67, 263-72.
Peer reviewed

Singh, M., Singh, P., Gaudray, G., Musumeci, L., Thielen, C., VAIRA, D., Vandergeeten, C., Delacroix, L., Van Gulck, E., Vanham, G., de Leval, L., Rahmouni, S., & MOUTSCHEN, M. (2012). An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rgammanull mice allows HIV replication and development of anti-HIV immune responses. PLoS ONE, 7 (6), 38491. doi:10.1371/journal.pone.0038491
Peer Reviewed verified by ORBi

Van Beckhoven, D., Buve, A., Ruelle, J., Seyler, L., Sasse, A., & MOUTSCHEN, M. (2012). A national cohort of HIV-infected patients in Belgium: design and main characteristics. Acta Clinica Belgica, 67 (5), 333-7. doi:10.2143/ACB.67.5.2062686
Peer Reviewed verified by ORBi

CAVALIER, E., MOUTSCHEN, M., & Brunel, E. (24 November 2011). Vitamine D et maladies infectieuses [Paper presentation]. Formations Continues en Biologie Clinique, Liège, Belgium.

Singh, M., Singh, P., VAIRA, D., Tasken, K., Rahmouni, S., & Moutschen, M. (03 October 2011). Humanized mice as a useful model to study HIV-1 induced immune activation, its mechanisms and potential therapeutic approaches. Retrovirology, 8, 62.
Peer Reviewed verified by ORBi

Herfs, M., Hubert, P., Moutschen, M., & Delvenne, P. (07 January 2011). Mucosal junctions: open doors to HPV and HIV infections? Trends in Microbiology, 19 (3), 114-120. doi:10.1016/j.tim.2010.12.006
Peer Reviewed verified by ORBi

DOUPAGNE, G., Toukouki, A., & Moutschen, M. (2011). Des interactions complexes entre les origines du VIH et sa pandemie, les activites coloniales en Afrique et la medecine coloniale Belge au Congo. Revue Médicale de Liège, 66 (9), 478-84.
Peer reviewed

FRIPPIAT, F., & Moutschen, M. (2011). Syphilis treatment in the human immunodeficiency virus-infected patient: follow the guidelines. Clinical Infectious Diseases, 53 (8), 845. doi:10.1093/cid/cir513
Peer Reviewed verified by ORBi

Vandekerckhove, L., Verhofstede, C., Demecheleer, E., De Wit, S., Florence, E., Fransen, K., Moutschen, M., Mostmans, W., Kabeya, K., Mackie, N., Plum, J., VAIRA, D., Van Baelen, K., Vandenbroucke, I., Van Eygen, V., Van Marck, H., Vogelaers, D., Geretti, A. M., & Stuyver, L. J. (2011). Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment. Journal of Antimicrobial Chemotherapy, 66 (2), 265-72. doi:10.1093/jac/dkq458

Mosenden, R.* , Singh, P.* , Cornez, I., Heglind, M., Ruppelt, A., MOUTSCHEN, M., Enerbäck, S., Rahmouni, S., & Tasken, K. (2011). Mice with Disrupted Type I Protein Kinase A Anchoring in T Cells Resist Retrovirus-Induced Immunodeficiency. Journal of Immunology, 186 (9), 5119-30. doi:10.4049/jimmunol.1100003
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Moutschen, P., Bourhaba, M., FRIPPIAT, F., GIOT, J.-B., MEURIS, C., Leonard, P., & Moutschen, M. (2011). A pauci-symptomatic case of documented Hantavirus (Puumala) infection in a patient under anti-TNF treatment. Journal of Clinical Virology, 50 (3), 247-8. doi:10.1016/j.jcv.2010.11.016
Peer Reviewed verified by ORBi

Rahier, J.-F., Moutschen, M., Van Gompel, A., Van Ranst, M., Louis, E., Segaert, S., Masson, P., & De Keyser, F. (2010). Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology, 49 (10), 1815-27. doi:10.1093/rheumatology/keq183
Peer Reviewed verified by ORBi

Geenen, V., Mottet, M., Dardenne, O., Kermani, H., Martens, H., François, J.-M., Galleni, M., Hober, D., Rahmouni, S., & Moutschen, M. (2010). Thymic self-antigens for the design of a negative/tolerogenic self-vaccination against type 1 diabetes. Current Opinion in Pharmacology, 10, 461-472. doi:10.1016/j.coph.2010.04.005
Peer Reviewed verified by ORBi

Steigbigel, R. T., Cooper, D. A., Teppler, H., Eron, J. J., Gatell, J. M., Kumar, P. N., Rockstroh, J. K., Schechter, M., Katlama, C., Markowitz, M., Yeni, P., Loutfy, M. R., Lazzarin, A., Lennox, J. L., Clotet, B., Zhao, J., Wan, H., Rhodes, R. R., Strohmaier, K. M., ... Moutschen, M. (Other coll.). (2010). Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 phase iii trials. Clinical Infectious Diseases, 50 (4), 605-12. doi:10.1086/650002
Peer Reviewed verified by ORBi

Maquet, D., Croisier, J.-L., Dupont, C., Moutschen, M., Ansseau, M., Zeevaert, B., & Crielaard, J.-M. (2010). Fibromyalgia and related conditions: Electromyogram profile during isometric muscle contraction. Joint Bone Spine, 77, 264–267. doi:10.1016/j.jbspin.2010.02.003
Peer Reviewed verified by ORBi

Moyle, G., Moutschen, M., Martinez, E., Domingo, P., Guaraldi, G., Raffi, F., Behrens, G., & Reiss, P. (2010). Epidemiology, assessment, and management of excess abdominal fat in persons with HIV infection. AIDS Reviews, 12 (1), 3-14.
Peer Reviewed verified by ORBi

Vandenbroucke, I., Van Marck, H., Mostmans, W., Van Eygen, V., Rondelez, E., Thys, K., Van Baelen, K., Fransen, K., Vaira, D., Kabeya, K., De Wit, S., Florence, E., Moutschen, M., Vandekerckhove, L., Verhofstede, C., & Stuyver, L. J. (2010). HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays. AIDS Research and Therapy, 7, 4. doi:10.1186/1742-6405-7-4
Peer Reviewed verified by ORBi

Maquet, D., Croisier, J.-L., Dupont, C., Moutschen, M., Ansseau, M., Zeevaert, B., & Crielaard, J.-M. (2010). Fibromyalgie et affections voisines : analyse du comportement électromyographique au cours d’un effort musculaire isométrique. Revue du Rhumatisme, 77, 296-300. doi:10.1016/j.rhum.2009.10.026
Peer Reviewed verified by ORBi

Wu, S.* , Vossius, S.* , Rahmouni, S.* , Miletic, A. V., Vang, T., Vazquez-Rodriguez, J., Cerignoli, F., Arimura, Y., Williams, S., Hayes, T., Moutschen, M., Vasile, S., Pellecchia, M., Mustelin, T., & Tautz, L. (12 November 2009). Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cells. Journal of Medicinal Chemistry, 52 (21), 6716-23. doi:10.1021/jm901016k
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Mukeba, D., Chandrikakumari, K., Giot, J.-B., Leonard, P., Meuris, C., Frippiat, F., & Moutschen, M. (2009). Autoimmune angioneurotic edema in a patient with Helicobacter pylori infection. Helicobacter, 14 (1), 9-11. doi:10.1111/j.1523-5378.2009.00651.x
Peer Reviewed verified by ORBi

Frippiat, F., Chandrikakumari, K., & Moutschen, M. (2009). Gentamicin in infective endocarditis: how to use it? Clinical Infectious Diseases, 49 (2), 320-1; author reply 321. doi:10.1086/600063
Peer Reviewed verified by ORBi

Rodger, A. J., Fox, Z., Lundgren, J. D., Kuller, L. H., Boesecke, C., Gey, D., Skoutelis, A., Goetz, M. B., Phillips, A. N., & Moutschen, M. (Other coll.). (2009). Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. Journal of Infectious Diseases, 200 (6), 973-83. doi:10.1086/605447
Peer Reviewed verified by ORBi

Reuse, S., Calao, M., Kabeya, K., Guiguen, A., GATOT, J.-S., Quivy, V., Vanhulle, C., Lamine, A., Vaira, D., Demonte, D., Martinelli, V., Veithen, E., Cherrier, T., Avettand, V., Poutrel, S., Piette, J., de Launoit, Y., Moutschen, M., Burny, A., ... Van Lint, C. (2009). Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. PLoS ONE, 4 (6), 6093. doi:10.1371/journal.pone.0006093
Peer Reviewed verified by ORBi

Scheen, A., & Moutschen, M. (2009). Les anticorps monoclonaux en thérapeutique. Revue Médicale de Liège, 64 (5-6), 233-6.
Peer reviewed

Morrhaye, G., Kermani, H., Legros, J.-J., Baron, F., Beguin, Y., Moutschen, M., Cheynier, R., Martens, H., & Geenen, V. (2009). Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients. PLoS ONE, 4 (5), 5668. doi:10.1371/journal.pone.0005668
Peer Reviewed verified by ORBi

Garcia, M. V., Mukeba-Tshialala, D., Vaira, D., & Moutschen, M. (2009). Triom une: la tritherapie du pauvre ? Revue Médicale de Liège, 64 (1), 32-6.
Peer reviewed

Hafraoui, K., Moutschen, M., Smet, J., Mascart, F., Schaaf-Lafontaine, N., & Fillet, G. (2009). Selective defect of anti-pneumococcal IgG in a patient with persistent polyclonal B cell lymphocytosis. European Journal of Internal Medicine, 20 (3), 62-5. doi:10.1016/j.ejim.2008.08.005
Peer Reviewed verified by ORBi

Moutschen, M., & Scheen, A. (2009). Bases immunologiques a la comprehension du concept d'anticorps monoclonal. Revue Médicale de Liège, 64 (5-6), 237-43.
Peer reviewed

Mocroft, A., Wyatt, C., Szczech, L., Neuhaus, J., El-Sadr, W., Tracy, R., Kuller, L., Shlipak, M., Angus, B., Klinker, H., Ross, M., & Moutschen, M. (Other coll.). (2009). Interruption of antiretroviral therapy is associated with increased plasma cystatin C. AIDS, 23 (1), 71-82. doi:10.1097/QAD.0b013e32831cc129
Peer Reviewed verified by ORBi

Katlama, C., Haubrich, R., Lalezari, J., Lazzarin, A., Madruga, J. V., Molina, J.-M., Schechter, M., Peeters, M., Picchio, G., Vingerhoets, J., Woodfall, B., De Smedt, G., & Moutschen, M. (Other coll.). (2009). Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials. AIDS, 23 (17), 2289-300. doi:10.1097/QAD.0b013e3283316a5e
Peer Reviewed verified by ORBi

Fox, Z., Phillips, A., Cohen, C., Neuhaus, J., Baxter, J., Emery, S., Hirschel, B., Hullsiek, K. H., Stephan, C., Lundgren, J., & Moutschen, M. (Other coll.). (2008). Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen. AIDS, 22 (17), 2279-89. doi:10.1097/QAD.0b013e328311d16f
Peer Reviewed verified by ORBi

Nkoghe, D., Moutschen, M., & Demonty, J. (2008). Lesions cerebrales demyelinisantes decouvertes chez un patient immunocompetent VIH-1+. Médecine et Maladies Infectieuses, 38 (9), 500-3. doi:10.1016/j.medmal.2008.06.010
Peer Reviewed verified by ORBi

Chandrikakumari, K., Giot, J.-B., de Leval, L., Creemers, E., Leonard, P., Mukeba, D., Moutschen, M., & Frippiat, F. (2008). Report of a case of Streptococcus agalactiae mycotic aneurysm and review of the literature. International Journal of Surgical Pathology, 16 (3), 314-9. doi:10.1177/1066896907310304
Peer Reviewed verified by ORBi

El-Sadr, W. M., Grund, B., Neuhaus, J., Babiker, A., Cohen, C. J., Darbyshire, J., Emery, S., Lundgren, J. D., Phillips, A., Neaton, J. D., & Moutschen, M. (Other coll.). (2008). Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Annals of Internal Medicine, 149 (5), 289-99. doi:10.7326/0003-4819-149-5-200809020-00003
Peer Reviewed verified by ORBi

Mafuko Nsabimana, J.-M., Moutschen, M., Thiry, E., & Meurens, F. (2008). Infection humaine par le virus B du singe en Afrique. Santé: Cahiers d'Études et de Recherches Francophones, 18 (1), 3-8. doi:10.1684/san.2008.0101
Peer Reviewed verified by ORBi

Steigbigel, R. T., Cooper, D. A., Kumar, P. N., Eron, J. E., Schechter, M., Markowitz, M., Loutfy, M. R., Lennox, J. L., Gatell, J. M., Rockstroh, J. K., Katlama, C., Yeni, P., Lazzarin, A., Clotet, B., Zhao, J., Chen, J., Ryan, D. M., Rhodes, R. R., Killar, J. A., ... Moutschen, M. (Other coll.). (2008). Raltegravir with optimized background therapy for resistant HIV-1 infection. New England Journal of Medicine, 359 (4), 339-54. doi:10.1056/NEJMoa0708975
Peer Reviewed verified by ORBi

Fatkenheuer, G., Nelson, M., Lazzarin, A., Konourina, I., Hoepelman, A. I. M., Lampiris, H., Hirschel, B., Tebas, P., Raffi, F., Trottier, B., Bellos, N., Saag, M., Cooper, D. A., Westby, M., Tawadrous, M., Sullivan, J. F., Ridgway, C., Dunne, M. W., Felstead, S., ... Moutschen, M. (Other coll.). (2008). Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection. New England Journal of Medicine, 359 (14), 1442-55. doi:10.1056/NEJMoa0803154
Peer Reviewed verified by ORBi

Gulick, R. M., Lalezari, J., Goodrich, J., Clumeck, N., DeJesus, E., Horban, A., Nadler, J., Clotet, B., Karlsson, A., Wohlfeiler, M., Montana, J. B., McHale, M., Sullivan, J., Ridgway, C., Felstead, S., Dunne, M. W., van der Ryst, E., Mayer, H., & Moutschen, M. (Other coll.). (2008). Maraviroc for previously treated patients with R5 HIV-1 infection. New England Journal of Medicine, 359 (14), 1429-41. doi:10.1056/NEJMoa0803152
Peer Reviewed verified by ORBi

Nayjib, B., Zeddou, M., Drion, P., Boniver, J., Tasken, K., Rahmouni, S., & Moutschen, M. (2008). In vivo administration of a PKA type I inhibitor (Rp-8-Br-cAMPS) restores T-cell responses in retrovirus-infected mice. Open Immunology Journal, 1, 20-24. doi:10.2174/1874226200801010020
Peer reviewed

Emery, S., Neuhaus, J. A., Phillips, A. N., Babiker, A., Cohen, C. J., Gatell, J. M., Girard, P.-M., Grund, B., Law, M., Losso, M. H., Palfreeman, A., Wood, R., & Moutschen, M. (2008). Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. Journal of Infectious Diseases, 197 (8), 1133-44. doi:10.1086/586713
Peer Reviewed verified by ORBi

Lundgren, J. D., Babiker, A., El-Sadr, W., Emery, S., Grund, B., Neaton, J. D., Neuhaus, J., Phillips, A. N., & Moutschen, M. (Other coll.). (2008). Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up. Journal of Infectious Diseases, 197 (8), 1145-55. doi:10.1086/529523
Peer Reviewed verified by ORBi

Cooper, D. A., Steigbigel, R. T., Gatell, J. M., Rockstroh, J. K., Katlama, C., Yeni, P., Lazzarin, A., Clotet, B., Kumar, P. N., Eron, J. E., Schechter, M., Markowitz, M., Loutfy, M. R., Lennox, J. L., Zhao, J., Chen, J., Ryan, D. M., Rhodes, R. R., Killar, J. A., ... Moutschen, M. (2008). Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection. New England Journal of Medicine, 359 (4), 355-65. doi:10.1056/NEJMoa0708978
Peer Reviewed verified by ORBi

Vercauteren, J., Derdelinckx, I., Sasse, A., Bogaert, M., Ceunen, H., De Roo, A., De Wit, S., Deforche, K., Echahidi, F., Fransen, K., Goffard, J.-C., Goubau, P., Goudeseune, E., Yombi, J.-C., Lacor, P., Liesnard, C., Moutschen, M., Piérard, D., Rens, R., ... van Laethem, K. (2008). Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006. AIDS Research and Human Retroviruses, 24 (3), 355-62. doi:10.1089/aid.2007.0212
Peer Reviewed verified by ORBi

Henkens, R., Delvenne, P., Arafa, M., Moutschen, M., Zeddou, M., Tautz, L., Boniver, J., Mustelin, T., & Rahmouni, S. (2008). Cervix carcinoma is associated with an up-regulation and nuclear localization of the dual-specificity protein phosphatase VHR. BMC Cancer, 8, 147. doi:10.1186/1471-2407-8-147
Peer Reviewed verified by ORBi

Bethlen, S., Chandrikakumari, K., de Leval, L., GIOT, J.-B., Mukeba, D., Leonard, P., Frippiat, F., Meuris, C., Delwaide, J., & Moutschen, M. (2008). Chronic hepatitis C infection in a patient with bone marrow hypoplasia. World Journal of Gastroenterology, 14 (26), 4238-40. doi:10.3748/wjg.14.4238
Peer Reviewed verified by ORBi

Frippiat, F., GIOT, J.-B., Chandrikakumari, K., Leonard, P., Meuris, C., & Moutschen, M. (2008). Syphilis en 2008: controverses et attitudes pratiques. Revue Médicale Suisse, 4 (168), 1823-7.
Peer Reviewed verified by ORBi

Frippiat, F., Chandrikakumari, K., & Moutschen, M. (2008). Decline of antibiotic use in primary care. The Lancet Infectious Diseases, 8 (5), 272; author reply 273. doi:10.1016/S1473-3099(08)70075-6
Peer Reviewed verified by ORBi

Sokal, E. M., Hoppenbrouwers, K., Vandermeulen, C., Moutschen, M., Leonard, P., Moreels, A., Haumont, M., Bollen, A., Smets, F., & Denis, M. (15 December 2007). Recombinant gp350 vaccine for infectious mononucleosis: A phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults. Journal of Infectious Diseases, 196 (12), 1749-1753. doi:10.1086/523813
Peer Reviewed verified by ORBi

Uurlings, F., & Moutschen, M. (November 2007). Patients infectes par le VIH. Et syndrome lipodystrophique. Revue Médicale de Liège, 62 (11), 669-74.
Peer reviewed

Mayasi, N., Chandrikakumari, K., Mukeba, D., GIOT, J.-B., Leonard, P., Hayette, M.-P., Moutschen, M., & Frippiat, F. (01 September 2007). A Patient with Hiv Infection, Cough, Asthenia, and Fever. Clinical Infectious Diseases, 45 (5), 662-3, 559-600. doi:10.1086/520656
Peer Reviewed verified by ORBi

Moutschen, M., Leonard, P., Sokal, E. M., Smets, F., Haumont, M., Mazzu, P., Bollen, A., Denamur, F., Peeters, P., Dubin, G., & Denis, M. (11 June 2007). Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults. Vaccine, 25 (24), 4697-4705. doi:10.1016/j.vaccine.2007.04.008
Peer Reviewed verified by ORBi

Frippiat, F., Waleffe, A., Soyeur, D., Leonard, P., GIOT, J.-B., & Moutschen, M. (June 2007). Uncomplicated left-sided infective endocarditis due to Escherichia coli, successfully treated with oral levofloxacin. Clinical Research in Cardiology, 96 (6), 401.
Peer Reviewed verified by ORBi

Castermans, E., Morrhaye, G., Marchand, S., Martens, H., Moutschen, M., Baron, F., Beguin, Y., & Geenen, V. (2007). Evaluation clinique de la fonction du thymus. Revue Médicale de Liège, 62 (11), 675-8.
Peer reviewed

Castermans, E., Morrhaye, G., Marchand, S., Martens, H., Moutschen, M., Geenen, V., Beguin, Y., & Baron, F. (2007). Evaluation de la thymopoiese: applications cliniques. Revue Médicale de Liège, 62 (12), 725-9.
Peer reviewed

Chandrika, K., Dellot, P., Frippiat, F., Giot, J.-B., Leonard, P., Marée, R., Mayasi, N., Meuris, C., Mukeba Tshialala, D., Rahmouni, S., Uurlings, F., Vaira, D., Wehenkel, L., Demonty, J., & Moutschen, M. (2007). Nouvelles approches dans la prise en charge de l'infection a VIH. Revue Médicale de Liège, 62 Spec No, 47-50.
Peer reviewed

Zeddou, M., Rahmouni, S., Vandamme, A., Jacobs, N., Frippiat, F., Leonard, P., SCHAAF-LAFONTAINE, N., Vaira, D., Boniver, J., & Moutschen, M. (2007). Downregulation of CD94/NKG2A inhibitory receptors on CD8+ T cells in HIV infection is more pronounced in subjects with detected viral load than in their aviraemic counterparts. Retrovirology, 4, 72. doi:10.1186/1742-4690-4-72
Peer Reviewed verified by ORBi

GIOT, J.-B., Mukeba Tshialala, D., Mayasi Ngongo, N., Frippiat, F., Leonard, P., & Moutschen, M. (2007). Avancees therapeutiques en pathologie infectieuse au cours de la derniere decennie. Revue Médicale de Liège, 62 (5-6, May-Jun), 377-83.
Peer reviewed

Vandergeeten, C., Quivy, V., Moutschen, M., Van Lint, C., Piette, J., & Legrand-Poels, S. (2007). HIV-1 protease inhibitors do not interfere with provirus transcription and host cell apoptosis induced by combined treatment TNF-alpha plus TSA. Biochemical Pharmacology, 73 (11), 1738-1748. doi:10.1016/j.bcp.2007.02.011
Peer Reviewed verified by ORBi

Rahmouni, S., Cerignoli, F., Alonso, A., Tsutji, T., Henkens, R., Zhu, C., Louis-dit-Sully, C., Moutschen, M., Jiang, W., & Mustelin, T. (May 2006). Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence. Nature Cell Biology, 8 (5), 524-U178. doi:10.1038/ncb1398
Peer Reviewed verified by ORBi

Zeddou, M., Boniver, J., Moutschen, M., & Rahmouni, S. (February 2006). Prostanglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway [Paper presentation]. Keystone Symposia - Innate Immunity, Banff, Canada.

Collette, G., Bourhaba, M., & Moutschen, M. (2006). Doit-on encore recommander le vaccin BCG? Revue Médicale de Liège, 61 (5-6, May-Jun), 430-2.
Peer reviewed

Zeddou, M., Rahmouni, S., VANDAMME, A., Schaaf-Lafontaine, N., & Moutschen, M. (2006). HIV viraemic patients downregulate CD94/NKG2A inhibitory receptors on NK as well as CD8 T cells in comparison with aviraemic counterparts [Poster presentation]. AIDS 2006 - XVI International AIDS Conference.

Bourhaba, M., GIOT, J.-B., Tshialala, D. M., Leonard, P., Frippiat, F., & Moutschen, M. (2006). L'Hantavirose fait encore parler d'elle. Revue Médicale de Liège, 61 (5-6, May-Jun), 322-8.
Peer reviewed

Rahmouni, S., Vang, T., Alonso, A., Williams, S., van Stipdonk, M., Soncini, C., Moutschen, M., Schoenberger, S. P., & Mustelin, T. (March 2005). Removal of C-terminal Src kinase from the immune synapse by a new binding protein. Molecular and Cellular Biology, 25 (6), 2227-2241. doi:10.1128/MCB.25.6.2227-2241.2005
Peer Reviewed verified by ORBi

Zeddou, M., Greimers, R., de Valensart, N., Nayjib, B., Tasken, K., Boniver, J., Moutschen, M., & Rahmouni, S. (2005). Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway. Biochemical Pharmacology, 70 (5), 714-24. doi:10.1016/j.bcp.2005.05.015
Peer Reviewed verified by ORBi

Moutschen, M. (2005). Anomalies des cellules de l'immunite naturelle et risque infectieux chez le patient diabetique. Revue Médicale de Liège, 60 (5-6, May-Jun), 541-4.
Peer reviewed

Rahmouni, S., Aandahl, E. M., Nayjib, B., Zeddou, M., Giannini, S., Verlaet, M., Greimers, R., Boniver, J., Tasken, K., & Moutschen, M. (15 December 2004). Cyclo-oxygenase type 2-dependent prostaglandin E-2 secretion is involved in retrovirus-induced T-cell dysfunction in mice. Biochemical Journal, 384 (Pt 3), 469-476. doi:10.1042/BJ20031859
Peer Reviewed verified by ORBi

Derdelinckx, I., Van Laethem, K., Maes, B., Schrooten, Y., De Wit, S. P., Florence, E., Fransen, K., Ribas, S. G., Marissens, D., Moutschen, M., Vaira, D., Zissis, G., Van Ranst, M., Van Wijngaerden, E., & Vandamme, A.-M. (15 December 2004). Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response. Journal of Acquired Immune Deficiency Syndromes, 37 (5), 1664-1666. doi:10.1097/00126334-200412150-00022
Peer Reviewed verified by ORBi

tasken, K., MOUTSCHEN, M., Rahmouni, S., Aandahl, E. M., Aukurst, P., Froland, S., Johansson, C., Hansson, V., & Klaveness, J. (29 April 2004). Use of COX-2 inhibitors for preventing immunodeficiency.

Elira Dokekias, A., Moutschen, M., Purhuence, M. F., Malanda, F., & Moyikoua, A. (2004). Myelome multiple et infection a VIH/SIDA : a propos de trois observations. Revue Médicale de Liège, 59 (2), 95-7.
Peer reviewed

Derdelinckx, I., Van Laethem, K., Maes, B., Schrooten, Y., De Schouwer, K., De Wit, S., Fransen, K., Garcia Ribas, S., Moutschen, M., Vaira, D., Zissis, G., Van Ranst, M., Van Wijngaerden, E., & Vandamme, A.-M. (28 November 2003). Performance of the VERSANT (R) HIV-1 Resistance Assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes. FEMS Immunology and Medical Microbiology, 39 (2), 119-124. doi:10.1016/S0928-8244(03)00240-2
Peer Reviewed verified by ORBi

Leonard, P., Moutschen, M., & Demonty, J. (June 2003). Prevention du paludisme chez l'adulte. Revue Médicale de Liège, 58 (6), 382-7.
Peer reviewed

Maquet, D., Croisier, J.-L., Moutschen, M., & Crielaard, J.-M. (March 2003). Isokinetic evaluation of muscular function in patients with chronic pain and fatigability. Isokinetics and Exercise Science, 11 (1), 73-74.
Peer Reviewed verified by ORBi

GIOT, J.-B., Franchimont, N., & Moutschen, M. (March 2003). Anomalies du metabolisme osseux chez les patients infectes par le HIV et traites par tritherapie. Revue Médicale de Liège, 58 (3), 155-63.
Peer reviewed

Geenen, V., Poulin, J. F., Dion, M. L., Martens, H., Castermans, E., Hansenne, I., Moutschen, M., Sekaly, R. P., & Cheynier, R. (2003). Quantification of T cell receptor rearrangement excision circles to estimate thymic function: an important new tool for endocrine-immune physiology. Journal of Endocrinology, 176 (3), 305-311. doi:10.1677/joe.0.1760305
Peer Reviewed verified by ORBi

TASKÉN, K., Moutschen, M., Rahmouni, S., Aandahl, E. M., AUKRUST, P., FRØLAND, S. S., JOHANSSON, C. C., HANSSON, V., & KLAVENESS, J. (31 January 2002). USE OF COX-2 INHIBITORS FOR PREVENTING IMMUNODEFICIENCY.

Geenen, V., PERRIER d'HAUTERIVE, S., Puit, M., Hazout, A., Goffin, F., Frankenne, F., Moutschen, M., & Foidart, J.-M. (2002). Autoimmunity and pregnancy: Theory and practice. Acta Clinica Belgica, 57 (6), 317-324. doi:10.1179/acb.2002.059
Peer Reviewed verified by ORBi

Debruyn, X., Nkoghe, D., Leonard, P., Moutschen, M., & Demonty, J. (January 2002). Les anomalies morphologiques et metaboliques liees aux traitements antiretroviraux. Revue Médicale de Liège, 57 (1), 23-8.
Peer reviewed

Delbecque, K., Radermecker, M., Leonard, P., Moutschen, M., Hermans, G., Boniver, J., & de Leval, L. (2002). L'image du mois. Malacoplasie pulmonaire a Rhodococcus equi chez un patient atteint du SIDA. Revue Médicale de Liège, 57 (11), 685-7.
Peer reviewed

Derdelinckx, I., Van Laethem, K., Maes, B., Schrooten, Y., Dewit, S., Florence, E., Fransen, K., Ribas, S. G., Marissens, D., Moutschen, M., Van Wijngaerden, E., Vaira, D., Zissis, G., Van Ranst, M., & Vandamme, A.-M. (2002). Drug resistance among therapy-naive HIV-infected patients studied by sequencing and VERSANT (TM) HIV-1 resistance assays (LiPA) has limited impact on treatment response. Antiviral Therapy, 7 (Suppl. 1), 181.
Peer Reviewed verified by ORBi

Nkoghe, D., Demonty, J., Léonard, P., Nnegue, S., Moutschen, M., & Kaye, O. (2002). La maladie de Still de l'adulte. Revue Médicale de Liège, 57 (4), 213 - 219.
Editorial Reviewed verified by ORBi

Blaise, P., Clevenbergh, P., Vaira, D., Moutschen, M., & Dellamonica, P. (2002). HIV resistance to antiretroviral drugs: Mechanisms, genotypic and phenotypic resistance testing in clinical practice. Acta Clinica Belgica, 57 (4, Jul-Aug), 191-201. doi:10.1179/acb.2002.041
Peer Reviewed verified by ORBi

Leonard, P., Nkoghe, D., Moutschen, M., & Demonty, J. (November 2001). Pharma-clinics comment je traite ... une infection par le VIH. IV. Les inhibiteurs de protease. Revue Médicale de Liège, 56 (11), 739-44.
Peer reviewed

Rahmouni, S., Aandahl, E. M., Trebak, M., Boniver, J., Tasken, K., & Moutschen, M. (2001). Increased Camp Levels and Protein Kinase (Pka) Type I Activation in Cd4+ T Cells and B Cells Contribute to Retrovirus-Induced Immunodeficiency of Mice (Maids): A Useful in Vivo Model for Drug Testing. FASEB Journal, 15 (8), 1466-1468. doi:10.1096/fj.00-0813fje
Peer Reviewed verified by ORBi

Nkoghe, D., Kola, L., Leonard, P., Demonty, J., & Moutschen, M. (July 2000). Hydroxyuree et infection par le VIH. Revue Médicale de Liège, 55 (7), 721-4.
Peer reviewed

Lechanteur, C., Moutschen, M., Princen, F., Lopez, M.-J., Franzen, E., Gielen, J., Bours, V., & Merville, M.-P. (May 2000). Antitumoral Vaccination with Granulocyte-Macrophage Colony-Stimulating Factor or Interleukin-12-Expressing Dhd/K12 Colon Adenocarcinoma Cells. Cancer Gene Therapy, 7 (5), 676-82. doi:10.1038/sj.cgt.7700152
Peer Reviewed verified by ORBi

Moutschen, M. (2000). Anomalies fonctionnelles des lymphocytes T dans un modèle murin d'infection rétrovirale [Post doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/76279

Baudoux, E., Blaffart, F., Bouffioux, C., Caprasse, M., Courtois, F., Cremasco, M.-R., De Pasqual, E., Fassotte, M.-F., Gillet, P., Lamy, M., Larbuisson, R., Lemaire, R., Merciny, M., Moutschen, M., Radermecker, M., Remy, B., & Sondag, D. (2000). La commission d'hemovigilance du CHU. Revue Médicale de Liège, 55 (9), 878-80.
Peer reviewed

Nkoghe, D., Moutschen, M., Leonard, P., & Demonty, J. (December 1999). Pharma-clinics comment je traite ... une infection par le VIH. III. Les inhibiteurs non nucléosidiques de la transcriptase inverse. Revue Médicale de Liège, 54 (12), 909-11.
Peer reviewed

Nkoghe, D., Leonard, P., Moutschen, M., & Demonty, J. (December 1999). Pharma-clinics le médicament du mois. La nevirapine. Viramune. Revue Médicale de Liège, 54 (12), 948-51.
Peer reviewed

de Leval, L., Debrus, S., Lane, P., Boniver, J., & Moutschen, M. (December 1999). Mice Transgenic for a Soluble Form of Murine Cytotoxic T Lymphocyte Antigen 4 Are Refractory to Murine Acquired Immune Deficiency Sydrome Development. Immunology, 98 (4), 630-8. doi:10.1046/j.1365-2567.1999.00900.x
Peer Reviewed verified by ORBi

Radermecker, R., Nkoghe, D., Labasse, J. M., Moutschen, M., & Demonty, J. (January 1999). L'image du mois. Kyste hydatique hépatique. Revue Médicale de Liège, 54 (1), 4-5.
Peer reviewed

Trebak, M., Lambert, C. A., Rahmouni, S., Debrus, S., Defresne, M.-P., Regnier, D., Boniver, J., & Moutschen, M. (15 September 1998). Decreased Protein Levels of the C-Cbl Protooncogene in Murine Aids. Cellular Immunology, 188 (2), 151-7. doi:10.1006/cimm.1998.1348
Peer Reviewed verified by ORBi

de Leval, L., Colombi, S., Debrus, S., Demoitie, M. A., Greimers, R., Linsley, P., Moutschen, M., & Boniver, J. (June 1998). Cd28-B7 Costimulatory Blockade by Ctla4ig Delays the Development of Retrovirus-Induced Murine Aids. Journal of Virology, 72 (6), 5285-90. doi:10.1128/jvi.72.6.5285-5290.1998
Peer Reviewed verified by ORBi

Jacobs, N., MOUTSCHEN, M., Franzen-Detrooz, E., Boniver, V., Boniver, J., & Delvenne, P. (April 1998). Organotypic Culture of HPV-Transformed Keratinocytes: A Model for Testing Lymphocyte Infiltration of (Pre)Neoplastic Lesions of the Uterine Cervix. Virchows Archiv, 432 (4), 323-30. doi:10.1007/s004280050173
Peer Reviewed verified by ORBi

al-Saleh, W., Giannini, S. L., Jacobs, N., Moutschen, M., Doyen, J., Boniver, J., & Delvenne, P. (March 1998). Correlation of T-Helper Secretory Differentiation and Types of Antigen-Presenting Cells in Squamous Intraepithelial Lesions of the Uterine Cervix. Journal of Pathology, 184 (3), 283-90. doi:10.1002/(SICI)1096-9896(199803)184:3<283::AID-PATH25>3.0.CO;2-K
Peer Reviewed verified by ORBi

Daniel, C., Baron, F., & Moutschen, M. (1998). Le cas clinique du mois. A propos d'une pancytopenie chez un patient seropositif. Revue Médicale de Liège, 53 (12), 732-4.
Peer reviewed

Jacobs, N., Giannini, S. L., Doyen, J., Baptista, A., Moutschen, M., Boniver, J., & Delvenne, P. (January 1998). Inverse Modulation of Il-10 and Il-12 in the Blood of Women with Preneoplastic Lesions of the Uterine Cervix. Clinical and Experimental Immunology, 111 (1), 219-24. doi:10.1046/j.1365-2249.1998.00437.x
Peer Reviewed verified by ORBi

Trebak, M., Lambert, C., Rahmouni, S., Greimers, R., Boniver, J., & Moutschen, M. (1998). Reciprocal regulation of protein tyrosine kinases p56lck and p59fyn, and altered tyrosine phosphorylation in murine AIDS. International Immunology, 10 (10), 1473-80. doi:10.1093/intimm/10.10.1473
Peer Reviewed verified by ORBi

Moutschen, M., Nkoghe, D., Leonard, P., & Demonty, J. (December 1997). Pharma-clinics. Comment je traite ... Une infection par le VIH. II. Inhibiteurs nucléosidiques de la transcriptase reverse. Revue Médicale de Liège, 52 (12), 750-2.
Peer reviewed

Moutschen, M., Nkoghe, D., Leonard, P., & Demonty, J. (October 1997). Comment je traite ... une infection par le VIH. I. Bases pathogéniques des choix thérapeutiques. Revue Médicale de Liège, 52 (10), 622-4.
Peer reviewed

Jacobs, N., Mazzoni, A., Mezzanzanica, D., Negri, D. R., Valota, O., Colnaghi, M. I., MOUTSCHEN, M., Boniver, J., & Canevari, S. (July 1997). Efficiency of T Cell Triggering by Anti-Cd3 Monoclonal Antibodies (Mab) with Potential Usefulness in Bispecific Mab Generation. Cancer Immunology, Immunotherapy, 44 (5), 257-64. doi:10.1007/s002620050381
Peer Reviewed verified by ORBi

Colombi, S., Moutschen, M., de Leval, L., Demoitie, M. A., Trebak, M., Martin, M. T., & Boniver, J. (February 1997). Peyer's Patches in Murine Aids: Dissociation between Lymphoproliferation and Anergy. Scandinavian Journal of Immunology, 45 (2), 175-81. doi:10.1046/j.1365-3083.1997.d01-390.x
Peer Reviewed verified by ORBi

Louis, E., Moutschen, M., de Marneffe, P., Malherbe, R., Closon, T., T'Jean, M., Demonty, J., & Belaiche, J. (1997). Extensive Ulcerative Colitis and Extraintestinal Manifestations in a Patient with Hiv Infection and Significant Cd4 T-Cell Lymphopenia. Gastroentérologie Clinique et Biologique, 21 (11), 884-7.
Peer Reviewed verified by ORBi

Moutschen, M., Trebak, M., Greimers, R., Colombi, & Boniver, J. (November 1996). Subset-Specific Analysis of Calcium Fluxes in Murine Aids. International Immunology, 8 (11), 1715-27. doi:10.1093/intimm/8.11.1715
Peer Reviewed verified by ORBi

Jacobs, N., Greimers, R., Mazzoni, A., Trebak, M., Schaaf-Lafontaine, N., Boniver, J., & Moutschen, M. (July 1996). Further Characterization of Cytotoxic T Cells Generated by Short-Term Culture of Human Peripheral Blood Lymphocytes with Interleukin-2 and Anti-Cd3 Mab. Cancer Immunology, Immunotherapy, 42 (6), 369-75. doi:10.1007/s002620050296
Peer Reviewed verified by ORBi

Greimers, R., Trebak, M., Moutschen, M., Jacobs, N., & Boniver, J. (01 March 1996). Improved Four-Color Flow Cytometry Method Using Fluo-3 and Triple Immunofluorescence for Analysis of Intracellular Calcium Ion ([Ca2+]I) Fluxes among Mouse Lymph Node B- and T-Lymphocyte Subsets. Cytometry, 23 (3), 205-17. doi:10.1002/(SICI)1097-0320(19960301)23:3<205::AID-CYTO4>3.0.CO;2-H
Peer Reviewed verified by ORBi

Moutschen, M. (June 1995). Pharma-clinics. Comment j'explore... une asthenie chronique. Revue Médicale de Liège, 50 (6), 268-9.
Peer reviewed

de Leval, L., Deprez, M., Colombi, S., Humblet, C., Defresne, M.-P., Boniver, J., & Moutschen, M. (1995). Morphological Changes of Thymus in Retrovirus-Induced Murine Acquired Immunodeficiency Syndrome (Maids). Pathology - Research and Practice, 191 (6), 506-12. doi:10.1016/S0344-0338(11)80869-1
Peer Reviewed verified by ORBi

Nikkels, A., Collignon, J., MOUTSCHEN, M., Paquet, P., Bouillenne, C., & Pierard, G. (03 December 1994). Maladie de Kaposi chez une patiente souffrant d'une immunodéficience acquise VIH négative. Presse Médicale, 23 (38), 1760-1761.
Peer Reviewed verified by ORBi

Moutschen, M., Jacobs, N., Hoyoux, C., Martin-Simonet, M.-T., Schaaf-Lafontaine, N., & Boniver, J. (1994). Presence of gd TcR+ Tumor Infiltrating Lymphocytes (TILs) in One Case of Pediatric Osteogenic Sarcoma. International Journal of Pediatric Hematology/Oncology.
Peer Reviewed verified by ORBi

Moutschen, M., Triffaux, J.-M., Demonty, J., Legros, J.-J., & Lefebvre, P. J. (1994). Pathogenic Tracks in Fatigue Syndromes. Acta Clinica Belgica, 49 (6), 274-89.
Peer Reviewed verified by ORBi

Moutschen, M., Colombi, S., Deprez, M., Van Wijk, F., Hotermans, C., Martin, M., Greimers, R., & Boniver, J. (1994). Population dynamics of CD4+ T cells lacking Thy-1 in murine retrovirus-induced immunodeficiency syndrome (MAIDS). Scandinavian Journal of Immunology, 39 (2), 216-24. doi:10.1111/j.1365-3083.1994.tb03363.x
Peer Reviewed verified by ORBi

Moutschen, M., Colombi, S., Deprez, M., Greimers, R., Van Wijk, F., Hotermans, C., & Boniver, J. (1994). Lymphocyte Lifespan in Murine Retrovirus-Induced Immunodeficiency. Advances in Experimental Medicine and Biology, 355, 177-81. doi:10.1007/978-1-4615-2492-2_30
Peer Reviewed verified by ORBi

Colombi, S., Deprez, M., de Leval, L., Humblet, C., Greimers, R., Defresne, M.-P., Boniver, J., & Moutschen, M. (1994). Thymus Involvement in Murine Acquired Immunodeficiency (Maids). Thymus, 23 (1), 27-37.
Peer Reviewed verified by ORBi

Jacobs, N., MOUTSCHEN, M., Boniver, J., Greimers, R., & Schaaf-Lafontaine, N. (February 1993). Efficient Immunoselection of Cytolytic Effectors with a Magnetic Cell Sorter. Research in Immunology, 144 (2), 141-50. doi:10.1016/0923-2494(93)80069-B
Peer Reviewed verified by ORBi

Boniver, J., Courtoy, R., Schaaf-Lafontaine, N., Martin-Simonet, M. T., Greimers, R., Rongy, A. M., Moutschen, M., Jacobs, N., Baudrihaye, M., Delvenne, P., Humblet, C., Lovens, D., Deman, J., Goffinet, G., & Defresne, M.-P. (1992). Cell Surface Receptors in Lymphoid Cells: From Cytochemistry to Molecular Biology and from a Phenotype to a Function. Progress in Histochemistry and Cytochemistry, 26 (1-4), 169-81. doi:10.1016/S0079-6336(11)80093-8
Peer Reviewed verified by ORBi

Moutschen, M., Scheen, A., & Lefebvre, P. (1992). Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabète et Métabolisme, 18 (3), 187-201.
Peer Reviewed verified by ORBi

Boniver, J., Schaaf-Lafontaine, N., Moutschen, M., Longree, L., Lovens-Degraef, D., Fassotte, M. F., Reginster, M. A., Simonet-Martin, M. T., & Baudrihaye, M. (01 February 1990). Réalisations et perspectives de l'immunothérapie du cancer. Revue Médicale de Liège, 45 (2), 41-8.
Peer reviewed

Beguin, Y., Fassotte, M.-F., Hay, F., Dokekias, A., Andrien, F., Bours, V., Moutschen, M., Runde, V., Bury, J., & Fillet, G. (1990). Greffes de moelle osseuse: bilan au CHU de Liege. Revue Médicale de Liège, 45 (6), 268-79.
Peer reviewed

Mendes, P., Andrien, F., PAQUOT, N., MOUTSCHEN, M., SCHEEN, A., D'ORIO, V., & Lefebvre, P. (1989). Traitement inhabituel de la thyreotoxicose. Acta Clinica Belgica, 44, 71.
Peer Reviewed verified by ORBi

Bontemps, J., Grandfils, C., MOUTSCHEN, M., Dandrifosse, G., & Schoffeniels, E. (25 March 1984). Experimental set up of a fast gel filtration technique for the determination of the binding of a chemically labelled form of tetrodotoxin to its solubilized receptor from excitable tissues [Poster presentation]. 125e Réunion de la Société Belge de Biochimie, Rhode Saint Genèse, Institut de Biologie Moléculaire.

Bontemps, J., Grandfils, C., Moutschen, M., Dandrifosse, G., & Schoffeniels, E. (1984). Experimental set up of a fast gel filtration technique for the determination of the binding of a chemically labelled form of tetrodotoxin to its solubilized receptor from excitable tissues. Archives Internationales de Physiologie et de Biochimie, 92, 8-9.
Peer Reviewed verified by ORBi

Contact ORBi